Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Nodule	5/126	5.052903542379685E-10	8.428243108689315E-7	0	0	273.7052341597796	5858.903558149272	COL1A1;CDH1;VIM;CD68;VEGFA
Aneurysm	5/152	1.3047354312728098E-9	1.0881493496815233E-6	0	0	225.0	4602.884749060962	COL1A1;COL1A2;VIM;CD68;VEGFA
Epithelioma	5/298	3.8337633129334534E-8	2.131572401991E-5	0	0	112.05346985210467	1913.518485294011	COL1A1;CDH1;VIM;CD68;VEGFA
leiomyosarcoma	4/114	6.885187436913462E-8	2.8711231611929136E-5	0	0	180.74545454545455	2980.729030672622	CDH1;VIM;CD68;VEGFA
Interstitial lung fibrosis	4/127	1.0641260813109752E-7	3.5499246072534135E-5	0	0	161.53658536585365	2593.6220082919717	COL1A1;VIM;CD68;VEGFA
Collagen Diseases	3/29	1.5272616551784111E-7	4.245787401395983E-5	0	0	460.75384615384615	7231.356200386841	COL1A1;COL1A2;VEGFA
Cirrhosis	5/433	2.466848307273614E-7	5.878147109331983E-5	0	0	76.18380062305296	1159.1482819482405	COL1A1;COL1A2;CDH1;VIM;VEGFA
Fibrosis	4/169	3.3541384493000414E-7	6.516515926078485E-5	0	0	120.16363636363636	1791.3875598073437	COL1A1;COL1A2;VIM;VEGFA
Keloid	4/171	3.516105715509974E-7	6.516515926078485E-5	0	0	118.7125748502994	1764.1569000676336	COL1A1;COL1A2;VIM;VEGFA
Congenital chromosomal disease	5/497	4.889335435887357E-7	8.155411507060112E-5	0	0	66.0569105691057	959.8755608336011	COL1A2;MECOM;CDH1;VIM;VEGFA
Arthritis, Psoriatic	4/201	6.715379805813337E-7	9.388978246516931E-5	0	0	100.48223350253807	1428.2238462277417	COL1A1;VIM;CD68;VEGFA
Carcinoma in situ of uterine cervix	3/47	6.754660609004987E-7	9.388978246516931E-5	0	0	272.0181818181818	3864.7970400373847	CDH1;VIM;CD68
Giant Cell Tumors	3/50	8.160167950922518E-7	9.899411865775701E-5	0	0	254.61702127659575	3569.432965531479	VIM;CD68;VEGFA
Congenital contractural arachnodactyly	4/212	8.308858880147471E-7	9.899411865775701E-5	0	0	95.11538461538461	1331.688944037976	COL1A1;COL1A2;CDH1;VIM
synovial sarcoma	4/217	9.119554754406697E-7	1.0140944886900248E-4	0	0	92.85915492957747	1291.454916785143	CDH1;VIM;CD68;VEGFA
Low grade glioma	3/62	1.5710479152192805E-6	1.541475248579859E-4	0	0	202.7084745762712	2708.9489649237594	CDH1;VIM;VEGFA
Cancer of Nasopharynx	3/62	1.5710479152192805E-6	1.541475248579859E-4	0	0	202.7084745762712	2708.9489649237594	MECOM;CDH1;VEGFA
Crumpled long bones	2/6	2.0982540726248864E-6	1.6892700071832335E-4	0	0	1665.6666666666667	21777.60051675149	COL1A1;COL1A2
Pulmonary arterial hypertension	3/70	2.2705024512610282E-6	1.6892700071832335E-4	0	0	178.43283582089552	2318.8255963917545	COL1A1;COL1A2;VEGFA
Liver Cirrhosis	5/683	2.3530701266531905E-6	1.6892700071832335E-4	0	0	47.47787610619469	615.3032871552216	COL1A1;COL1A2;CDH1;VIM;VEGFA
Mammary Neoplasms	7/2387	2.4528638272134278E-6	1.6892700071832335E-4	0	0	51.8	669.165573101731	COL1A1;COL1A2;MECOM;CDH1;VIM;CD68;VEGFA
Marfan Syndrome	3/73	2.578312212339619E-6	1.6892700071832335E-4	0	0	170.76	2197.403809663263	COL1A1;COL1A2;VEGFA
Pancreatic Ductal Adenocarcinoma	5/701	2.6747401332523004E-6	1.6892700071832335E-4	0	0	46.206896551724135	592.9111089851484	MECOM;CDH1;VIM;CD68;VEGFA
Ovarian Cysts	3/75	2.7981749157843965E-6	1.6892700071832335E-4	0	0	166.0	2122.5661660703795	COL1A2;CD68;VEGFA
Broad long bones	2/7	2.9369802283161735E-6	1.6892700071832335E-4	0	0	1332.4666666666667	16973.131805450383	COL1A1;COL1A2
Myxoinflammatory fibroblastic sarcoma	2/7	2.9369802283161735E-6	1.6892700071832335E-4	0	0	1332.4666666666667	16973.131805450383	VIM;CD68
Papillary cystic tumor	2/7	2.9369802283161735E-6	1.6892700071832335E-4	0	0	1332.4666666666667	16973.131805450383	CDH1;VIM
Pulmonary Valve Insufficiency	2/7	2.9369802283161735E-6	1.6892700071832335E-4	0	0	1332.4666666666667	16973.131805450383	COL1A1;COL1A2
Ehlers-Danlos syndrome type 1	2/7	2.9369802283161735E-6	1.6892700071832335E-4	0	0	1332.4666666666667	16973.131805450383	COL1A1;COL1A2
Ehlers-Danlos Syndrome, Type IV	2/8	3.9152037969490335E-6	1.9789575555487842E-4	0	0	1110.3333333333333	13824.364138043773	COL1A1;COL1A2
Beading of ribs	2/8	3.9152037969490335E-6	1.9789575555487842E-4	0	0	1110.3333333333333	13824.364138043773	COL1A1;COL1A2
Multiple prenatal fractures	2/8	3.9152037969490335E-6	1.9789575555487842E-4	0	0	1110.3333333333333	13824.364138043773	COL1A1;COL1A2
Chronic cholecystitis	2/8	3.9152037969490335E-6	1.9789575555487842E-4	0	0	1110.3333333333333	13824.364138043773	CDH1;VEGFA
Hurthle Cell Tumor	3/85	4.085272815128847E-6	2.0041867810690933E-4	0	0	145.6829268292683	1807.6515363015085	CDH1;VIM;VEGFA
Nasopharyngeal Neoplasms	3/89	4.693651562130212E-6	2.1487019472467758E-4	0	0	138.87906976744185	1703.9489281687297	COL1A1;MECOM;CDH1
Osteogenesis imperfecta, dominant perinatal lethal	2/9	5.032841318877048E-6	2.1487019472467758E-4	0	0	951.6666666666666	11609.882108963659	COL1A1;COL1A2
Decreased calvarial ossification	2/9	5.032841318877048E-6	2.1487019472467758E-4	0	0	951.6666666666666	11609.882108963659	COL1A1;COL1A2
Premature osteoarthritis	2/9	5.032841318877048E-6	2.1487019472467758E-4	0	0	951.6666666666666	11609.882108963659	COL1A1;COL1A2
Protrusio acetabuli	2/9	5.032841318877048E-6	2.1487019472467758E-4	0	0	951.6666666666666	11609.882108963659	COL1A1;COL1A2
Liver Cirrhosis, Experimental	5/801	5.152762463421524E-6	2.1487019472467758E-4	0	0	40.19262981574539	489.38455977642184	COL1A1;COL1A2;VIM;CD68;VEGFA
AMYOTROPHIC LATERAL SCLEROSIS 1	3/94	5.534904511305087E-6	2.251761152404118E-4	0	0	131.2153846153846	1588.2882572759552	VIM;CD68;VEGFA
Aortic Aneurysm	3/96	5.897544132097508E-6	2.3421675267472963E-4	0	0	128.38064516129032	1545.8280801374915	COL1A1;CD68;VEGFA
Lobstein Disease	2/10	6.2898093131455335E-6	2.3592733067608288E-4	0	0	832.6666666666666	9972.498783119754	COL1A1;COL1A2
Poor wound healing	2/10	6.2898093131455335E-6	2.3592733067608288E-4	0	0	832.6666666666666	9972.498783119754	COL1A1;COL1A2
Aortic Aneurysm, Thoracic	3/99	6.470487258926191E-6	2.3592733067608288E-4	0	0	124.35	1485.7660242814022	COL1A1;COL1A2;VEGFA
Endometrial Carcinoma	5/840	6.506389215287657E-6	2.3592733067608288E-4	0	0	38.237524950099804	456.66027986595793	MECOM;CDH1;VIM;CD68;VEGFA
Myeloid Leukemia, Chronic	5/876	7.992006711115192E-6	2.836312168965987E-4	0	0	36.588212782242636	429.43836618981874	MECOM;CDH1;VIM;CD68;VEGFA
Mesothelioma	4/383	8.720311768823937E-6	2.96961846187699E-4	0	0	51.74934036939314	602.8723410104632	CDH1;VIM;CD68;VEGFA
Abortion, Tubal	3/110	8.884848222799258E-6	2.96961846187699E-4	0	0	111.50467289719626	1296.9290456785186	COL1A1;COL1A2;CD68
Invasive carcinoma of breast	4/385	8.901733998432225E-6	2.96961846187699E-4	0	0	51.47244094488189	598.5866286088367	CDH1;VIM;CD68;VEGFA
Hereditary Connective Tissue Disorder	2/12	9.221402746009655E-6	3.008326112332219E-4	0	0	666.0666666666667	7722.365870178143	COL1A1;COL1A2
Skin Erosion	3/112	9.379455712658977E-6	3.008326112332219E-4	0	0	109.44770642201834	1267.074873950551	VIM;CD68;VEGFA
Carcinoma breast stage IV	4/392	9.558829973237866E-6	3.008326112332219E-4	0	0	50.52577319587629	583.9791716830027	MECOM;CDH1;VIM;VEGFA
Brain and/or spinal cord issue	2/13	1.0895861205044152E-5	3.133499394829939E-4	0	0	605.4848484848485	6918.952591288204	COL1A1;COL1A2
Breech Presentation	2/13	1.0895861205044152E-5	3.133499394829939E-4	0	0	605.4848484848485	6918.952591288204	COL1A1;COL1A2
Neonatal short-limb short stature	2/13	1.0895861205044152E-5	3.133499394829939E-4	0	0	605.4848484848485	6918.952591288204	COL1A1;COL1A2
Osteogenesis imperfecta type III (disorder)	2/13	1.0895861205044152E-5	3.133499394829939E-4	0	0	605.4848484848485	6918.952591288204	COL1A1;COL1A2
Osteogenesis imperfecta type IV (disorder)	2/13	1.0895861205044152E-5	3.133499394829939E-4	0	0	605.4848484848485	6918.952591288204	COL1A1;COL1A2
Premature Birth	3/119	1.1253502996126815E-5	3.1814988131422927E-4	0	0	102.80689655172414	1171.4672221578705	COL1A1;COL1A2;VEGFA
Malignant neoplasm of kidney	4/421	1.2670867215944486E-5	3.475268753133078E-4	0	0	46.94244604316547	529.3326503970395	COL1A1;CDH1;VIM;VEGFA
Biconcave vertebral bodies	2/14	1.270931618352025E-5	3.475268753133078E-4	0	0	555.0	6256.6122779936395	COL1A1;COL1A2
Arthropathy	3/125	1.304427965633335E-5	3.5093320107683915E-4	0	0	97.72131147540983	1099.0873096928335	COL1A1;CD68;VEGFA
Degenerative polyarthritis	5/976	1.3560100322154117E-5	3.590197990056042E-4	0	0	32.64847236525918	365.93644802804215	COL1A1;COL1A2;VIM;CD68;VEGFA
Pulmonary Fibrosis	4/432	1.4028004026564074E-5	3.656048549423262E-4	0	0	45.71028037383178	510.7874682703831	COL1A1;COL1A2;CDH1;VEGFA
Platybasia	2/15	1.4661684218577711E-5	3.7624137348596343E-4	0	0	512.2820512820513	5701.83907495754	COL1A1;COL1A2
precancerous lesions	3/132	1.5360328590979298E-5	3.88197395299295E-4	0	0	92.38604651162791	1023.981296663492	CDH1;VIM;VEGFA
Tumor thrombus	2/16	1.675288186561917E-5	4.1205004894940916E-4	0	0	475.6666666666667	5230.877918345019	VIM;VEGFA
Amyotrophic Lateral Sclerosis, Sporadic	3/136	1.679820343438838E-5	4.1205004894940916E-4	0	0	89.58947368421053	984.9680511394234	VIM;CD68;VEGFA
Spontaneous abortion	3/138	1.754933324804702E-5	4.242360559093106E-4	0	0	88.25333333333333	966.417650128529	COL1A1;COL1A2;CD68
Relative short stature	2/17	1.8982825688105916E-5	4.337445650378174E-4	0	0	443.93333333333334	4826.432500640291	COL1A1;COL1A2
Genu recurvatum	2/17	1.8982825688105916E-5	4.337445650378174E-4	0	0	443.93333333333334	4826.432500640291	COL1A1;COL1A2
Mild short stature	2/17	1.8982825688105916E-5	4.337445650378174E-4	0	0	443.93333333333334	4826.432500640291	COL1A1;COL1A2
Otosclerosis	2/17	1.8982825688105916E-5	4.337445650378174E-4	0	0	443.93333333333334	4826.432500640291	COL1A1;COL1A2
Lip and Oral Cavity Carcinoma	4/473	2.005107271914428E-5	4.519620175071981E-4	0	0	41.62686567164179	450.28729287608127	CDH1;VIM;CD68;VEGFA
Acute Promyelocytic Leukemia	4/475	2.0386822612421568E-5	4.534029349002556E-4	0	0	41.445859872611464	447.64105833135443	MECOM;VIM;CD68;VEGFA
Monosomy	3/147	2.1204363342965804E-5	4.653799744219337E-4	0	0	82.7	889.9598060163399	MECOM;VIM;CD68
Malignant neoplasm of mouth	4/492	2.3411266396375306E-5	4.983275789296189E-4	0	0	39.967213114754095	426.14214387857896	CDH1;VIM;CD68;VEGFA
Leukemia, Monocytic, Chronic	2/19	2.3858618257288482E-5	4.983275789296189E-4	0	0	391.6666666666667	4168.651312579773	MECOM;VEGFA
Squamous cell carcinoma of tongue	3/153	2.3900603305976925E-5	4.983275789296189E-4	0	0	79.368	844.6030529801442	CDH1;VIM;VEGFA
Cervical Squamous Cell Carcinoma	3/153	2.3900603305976925E-5	4.983275789296189E-4	0	0	79.368	844.6030529801442	CDH1;VIM;VEGFA
Invasive Carcinoma	3/154	2.4370864531804834E-5	5.018592844327217E-4	0	0	78.83841059602649	837.4312326431569	CDH1;VIM;VEGFA
Renal carcinoma	4/500	2.4943889840822946E-5	5.073952226157643E-4	0	0	39.306451612903224	416.6044291950714	COL1A1;CDH1;VIM;VEGFA
Sick Sinus Syndrome	2/20	2.650430025143172E-5	5.083991045787357E-4	0	0	369.8888888888889	3897.964407357134	COL1A2;VEGFA
Soft skin	2/20	2.650430025143172E-5	5.083991045787357E-4	0	0	369.8888888888889	3897.964407357134	COL1A1;COL1A2
Tonsillar Carcinoma	2/20	2.650430025143172E-5	5.083991045787357E-4	0	0	369.8888888888889	3897.964407357134	CDH1;VIM
Velvety skin	2/20	2.650430025143172E-5	5.083991045787357E-4	0	0	369.8888888888889	3897.964407357134	COL1A1;COL1A2
Chronic Lymphocytic Leukemia	5/1120	2.6517219483423265E-5	5.083991045787357E-4	0	0	28.216741405082214	297.34001426182556	MECOM;CDH1;VIM;CD68;VEGFA
Heartburn	3/162	2.8354523320950613E-5	5.310113341021502E-4	0	0	74.84150943396226	783.6447881096428	COL1A1;COL1A2;VEGFA
Metastatic malignant neoplasm to brain	3/163	2.8880735184554563E-5	5.310113341021502E-4	0	0	74.37	777.3402125338343	CDH1;CD68;VEGFA
Fibrolamellar Hepatocellular Carcinoma	2/21	2.928839492649749E-5	5.310113341021502E-4	0	0	350.4035087719298	3657.623672658719	CDH1;CD68
Atrophic scar	2/21	2.928839492649749E-5	5.310113341021502E-4	0	0	350.4035087719298	3657.623672658719	COL1A1;COL1A2
Pseudomyxoma Peritonei	2/21	2.928839492649749E-5	5.310113341021502E-4	0	0	350.4035087719298	3657.623672658719	CDH1;VIM
Follicular thyroid carcinoma	3/167	3.104997913041375E-5	5.509719701013845E-4	0	0	72.54146341463415	752.9740371868287	VIM;CD68;VEGFA
Transitional cell carcinoma of bladder	3/167	3.104997913041375E-5	5.509719701013845E-4	0	0	72.54146341463415	752.9740371868287	CDH1;VIM;VEGFA
Angiomyolipoma of kidney	2/22	3.2210818955169004E-5	5.655541686023358E-4	0	0	332.8666666666667	3442.9092260043108	VIM;CD68
Fibrosis, Liver	4/545	3.4987952861621565E-5	6.003351403051259E-4	0	0	35.953789279112755	368.9040979344578	COL1A1;COL1A2;VIM;VEGFA
Abnormality of the thorax	2/23	3.527148905869445E-5	6.003351403051259E-4	0	0	317.0	3250.0220838564323	COL1A1;COL1A2
Camurati-Engelmann Syndrome	2/23	3.527148905869445E-5	6.003351403051259E-4	0	0	317.0	3250.0220838564323	COL1A2;VEGFA
Intrahepatic Cholangiocarcinoma	3/177	3.693679793474664E-5	6.223290803551251E-4	0	0	68.33793103448276	697.4775806321343	CDH1;VIM;VEGFA
Hydrops Fetalis, Non-Immune	2/24	3.847032196562326E-5	6.229951168801903E-4	0	0	302.57575757575756	3075.8712232612634	COL1A1;COL1A2
Asphyxia Neonatorum	2/24	3.847032196562326E-5	6.229951168801903E-4	0	0	302.57575757575756	3075.8712232612634	COL1A1;VEGFA
Dentinogenesis Imperfecta	2/24	3.847032196562326E-5	6.229951168801903E-4	0	0	302.57575757575756	3075.8712232612634	COL1A1;COL1A2
Elastosis perforans serpiginosa	2/24	3.847032196562326E-5	6.229951168801903E-4	0	0	302.57575757575756	3075.8712232612634	COL1A1;VEGFA
Systemic Scleroderma	4/562	3.946561390096952E-5	6.329677306424728E-4	0	0	34.82795698924731	353.15829794707224	COL1A1;COL1A2;CD68;VEGFA
Liver carcinoma	7/3593	4.053518966168368E-5	6.439304414827465E-4	0	0	32.025097601784715	323.8807031604416	COL1A1;COL1A2;MECOM;CDH1;VIM;CD68;VEGFA
Papillary thyroid carcinoma	4/571	4.2000418397286216E-5	6.609122442139001E-4	0	0	34.25925925925926	345.2590242425407	CDH1;VIM;CD68;VEGFA
Malignant neoplasm of endometrium	4/577	4.375571329793745E-5	6.820984091678474E-4	0	0	33.890052356020945	340.15067214816156	CDH1;VIM;CD68;VEGFA
Uterine Corpus Cancer	4/579	4.435265684240384E-5	6.850021445660149E-4	0	0	33.76869565217391	338.4750484750855	CDH1;VIM;CD68;VEGFA
Tibial bowing	2/26	4.528214327454185E-5	6.929414218526221E-4	0	0	277.3333333333333	2774.0537874782267	COL1A1;COL1A2
Medulloblastoma	4/590	4.7743871320786945E-5	7.239707033006602E-4	0	0	33.1160409556314	329.49334304010716	COL1A2;CDH1;VIM;VEGFA
Increased susceptibility to fractures	2/27	4.889496527853119E-5	7.347459647260362E-4	0	0	266.2266666666667	2642.522265790654	COL1A1;COL1A2
Left Ventricular Hypertrophy	3/203	5.557146147245091E-5	8.202937852747621E-4	0	0	59.376	581.7565936398006	COL1A1;COL1A2;VEGFA
Malignant neoplasm of gallbladder	3/203	5.557146147245091E-5	8.202937852747621E-4	0	0	59.376	581.7565936398006	CDH1;VIM;VEGFA
Thymoma	3/205	5.721695441238901E-5	8.371743856128497E-4	0	0	58.78217821782178	574.2231305680001	MECOM;CDH1;VEGFA
Nonalcoholic Steatohepatitis	3/209	6.0603434906246496E-5	8.739714631463784E-4	0	0	57.62912621359223	559.6456068195707	COL1A1;CD68;VEGFA
Epithelial ovarian cancer	5/1329	6.077979000298556E-5	8.739714631463784E-4	0	0	23.49949647532729	228.13906245460706	MECOM;CDH1;VIM;CD68;VEGFA
Stomach Carcinoma	6/2378	6.350118199082119E-5	9.052989022281175E-4	0	0	22.284991568296796	215.37223218372282	COL1A1;COL1A2;CDH1;VIM;CD68;VEGFA
Aortic Valve Insufficiency	3/214	6.501853893801725E-5	9.190756182085828E-4	0	0	56.24928909952607	542.2902902531877	COL1A1;COL1A2;VEGFA
Malignant neoplasm of stomach	6/2398	6.665022146947528E-5	9.342232723620568E-4	0	0	22.073578595317727	212.2606837589188	COL1A1;COL1A2;CDH1;VIM;CD68;VEGFA
Giant Cell Fibroblastoma	2/32	6.902486337983755E-5	9.43716984570238E-4	0	0	221.8	2125.0755102787357	COL1A1;VIM
Slender long bone	2/32	6.902486337983755E-5	9.43716984570238E-4	0	0	221.8	2125.0755102787357	COL1A1;COL1A2
Dermatofibrosarcoma Protuberans	2/32	6.902486337983755E-5	9.43716984570238E-4	0	0	221.8	2125.0755102787357	COL1A1;VIM
Nasal Polyps	3/219	6.964002859751936E-5	9.443867292736772E-4	0	0	54.93333333333333	525.8312620474117	VIM;CD68;VEGFA
Angiomyolipoma	2/33	7.34634191149693E-5	9.648581345178646E-4	0	0	214.63440860215053	2043.045476334213	VIM;CD68
Metabolic Bone Disorder	2/33	7.34634191149693E-5	9.648581345178646E-4	0	0	214.63440860215053	2043.045476334213	COL1A1;VEGFA
Primary Lesion	2/33	7.34634191149693E-5	9.648581345178646E-4	0	0	214.63440860215053	2043.045476334213	COL1A2;VIM
Disproportionate short-limb short stature	2/33	7.34634191149693E-5	9.648581345178646E-4	0	0	214.63440860215053	2043.045476334213	COL1A1;COL1A2
Exanthema	3/225	7.54644948787443E-5	9.833966988886367E-4	0	0	53.432432432432435	507.17254181726855	VIM;CD68;VEGFA
Chronic Obstructive Airway Disease	4/669	7.800568391631146E-5	9.936607883638926E-4	0	0	29.063157894736843	274.90053043490957	COL1A1;VIM;CD68;VEGFA
Carcinoma, Ehrlich Tumor	2/34	7.803930652018581E-5	9.936607883638926E-4	0	0	207.91666666666666	1966.537777625364	VIM;VEGFA
Sarcoma, Spindle Cell	2/34	7.803930652018581E-5	9.936607883638926E-4	0	0	207.91666666666666	1966.537777625364	CDH1;VEGFA
MYELODYSPLASTIC SYNDROME	4/683	8.456460559655692E-5	0.0010633451971964667	0	0	28.443298969072163	266.74110847454966	MECOM;CDH1;CD68;VEGFA
Epstein-Barr Virus Infections	3/234	8.478711704264393E-5	0.0010633451971964667	0	0	51.32727272727273	481.21201627748263	CDH1;VIM;CD68
Sarcoidosis	3/236	8.695648688752665E-5	0.0010743957046547737	0	0	50.88154506437768	475.7476726572036	COL1A1;CD68;VEGFA
Uveal melanoma	3/236	8.695648688752665E-5	0.0010743957046547737	0	0	50.88154506437768	475.7476726572036	VIM;CD68;VEGFA
EAR, PATELLA, SHORT STATURE SYNDROME	2/36	8.760274454585359E-5	0.0010744218963417926	0	0	195.66666666666666	1828.0546203524366	COL1A1;VEGFA
Meningioma, benign, no ICD-O subtype	3/241	9.253857309473343E-5	0.0011031452550808697	0	0	49.8	462.53667269818015	CDH1;CD68;VEGFA
Metastatic Prostate Carcinoma	3/241	9.253857309473343E-5	0.0011031452550808697	0	0	49.8	462.53667269818015	CDH1;VIM;VEGFA
Hereditary pyropoikilocytosis	2/37	9.259012932333438E-5	0.0011031452550808697	0	0	190.06666666666666	1765.2114783882112	COL1A1;COL1A2
Tubular Aggregate Myopathy	2/37	9.259012932333438E-5	0.0011031452550808697	0	0	190.06666666666666	1765.2114783882112	VIM;VEGFA
Gross motor development delay	2/38	9.771451414336942E-5	0.00113923015772353	0	0	184.77777777777777	1706.1383034595449	COL1A1;COL1A2
Hyperactive behavior	4/709	9.780925054126464E-5	0.00113923015772353	0	0	27.357446808510637	252.57739236050003	MECOM;CDH1;VIM;VEGFA
Gastroesophageal reflux disease	3/246	9.835080498332631E-5	0.00113923015772353	0	0	48.762962962962966	449.9343879967386	COL1A1;COL1A2;VEGFA
Kidney Neoplasm	3/246	9.835080498332631E-5	0.00113923015772353	0	0	48.762962962962966	449.9343879967386	CDH1;VIM;VEGFA
Thyroid carcinoma	4/721	1.0441008095789022E-4	0.0012010759657776614	0	0	26.88284518828452	246.43999705580268	CDH1;VIM;CD68;VEGFA
Acute Coronary Syndrome	3/255	1.0940663990166563E-4	0.0012499333928491663	0	0	47.0	428.6606318728782	VIM;CD68;VEGFA
Adenoma of large intestine	3/258	1.1326510508889297E-4	0.0012852122128453978	0	0	46.44	421.9435964610949	CDH1;VIM;VEGFA
Malignant Pleural Mesothelioma	3/260	1.1588632582563806E-4	0.0013060702126835423	0	0	46.0739299610895	417.5634565699608	COL1A2;VIM;VEGFA
Reduced bone mineral density	2/42	1.1958039723947946E-4	0.0013122375170753404	0	0	166.26666666666668	1501.6409967738412	COL1A1;COL1A2
Hyperextensible skin	2/42	1.1958039723947946E-4	0.0013122375170753404	0	0	166.26666666666668	1501.6409967738412	COL1A1;COL1A2
Cervical intraepithelial neoplasia grade 2	2/42	1.1958039723947946E-4	0.0013122375170753404	0	0	166.26666666666668	1501.6409967738412	VIM;VEGFA
Other ureteric obstruction	2/42	1.1958039723947946E-4	0.0013122375170753404	0	0	166.26666666666668	1501.6409967738412	COL1A1;COL1A2
Endometriosis	4/749	1.210787065897277E-4	0.0013199953110566392	0	0	25.83489932885906	233.0067591899956	COL1A1;CDH1;CD68;VEGFA
Carcinoma of urinary bladder, superficial	2/43	1.253885401588909E-4	0.0013581044479547405	0	0	162.20325203252034	1457.2491531056257	CDH1;VEGFA
Cytomegalovirus Infections	3/270	1.2958963206201207E-4	0.0013864794626942706	0	0	44.325842696629216	396.7667250488624	CDH1;VIM;VEGFA
Blue sclera	2/44	1.313331865142055E-4	0.0013864794626942706	0	0	158.33333333333334	1415.1474004141428	COL1A1;COL1A2
Oral Submucous Fibrosis	2/44	1.313331865142055E-4	0.0013864794626942706	0	0	158.33333333333334	1415.1474004141428	COL1A1;COL1A2
Osteosclerosis	2/44	1.313331865142055E-4	0.0013864794626942706	0	0	158.33333333333334	1415.1474004141428	COL1A1;VEGFA
Nasopharyngeal carcinoma	4/782	1.4313942804532783E-4	0.0015016136225132505	0	0	24.696658097686374	218.60719563348513	MECOM;CDH1;VIM;VEGFA
Experimental Organism Basal Cell Carcinoma	3/282	1.473834120655313E-4	0.001536472070783164	0	0	42.39354838709677	374.0159411663826	COL1A2;CD68;VEGFA
Anaplasia	3/283	1.4893438361127302E-4	0.0015429972165441205	0	0	42.24	372.2190796879828	CDH1;VIM;VEGFA
Noninfiltrating Intraductal Carcinoma	3/287	1.552450353002644E-4	0.0015952747670756988	0	0	41.63661971830986	365.1742154148496	CDH1;VIM;VEGFA
Corneal Neovascularization	2/48	1.564751534800524E-4	0.0015952747670756988	0	0	144.53623188405797	1266.5151113505071	VIM;VEGFA
Aortic Aneurysm, Abdominal	3/288	1.5684955743430133E-4	0.0015952747670756988	0	0	41.48842105263158	363.44783879785746	COL1A2;CD68;VEGFA
Heart failure	4/815	1.6801177499538568E-4	0.0016984463072260809	0	0	23.651048088779284	205.5625284690845	COL1A1;COL1A2;CD68;VEGFA
Carcinosarcoma	2/50	1.6986300982591541E-4	0.001706816267407391	0	0	138.5	1202.2517804391236	VIM;VEGFA
Idiopathic pulmonary arterial hypertension	3/297	1.7178074913492072E-4	0.0017157502368685496	0	0	40.2	348.5055226666076	COL1A1;COL1A2;VEGFA
Adenocarcinoma Of Esophagus	3/299	1.7522015731412344E-4	0.0017343360401159383	0	0	39.924324324324324	345.32413903203826	CDH1;VIM;VEGFA
Metaplasia	2/51	1.7676086739790736E-4	0.0017343360401159383	0	0	135.66666666666666	1172.256699198754	CDH1;VEGFA
Convex nasal ridge	2/51	1.7676086739790736E-4	0.0017343360401159383	0	0	135.66666666666666	1172.256699198754	COL1A1;COL1A2
Cutaneous Melanoma	3/301	1.7870427476800554E-4	0.0017431504696668611	0	0	39.65234899328859	342.190977500301	CDH1;VIM;VEGFA
Idiopathic crescentic glomerulonephritis	2/52	1.8379456792760984E-4	0.0017618927546163977	0	0	132.94666666666666	1143.5662661624315	CD68;VEGFA
Invasive Lobular Breast Carcinoma	2/52	1.8379456792760984E-4	0.0017618927546163977	0	0	132.94666666666666	1143.5662661624315	CDH1;VEGFA
Congenital neurologic anomalies	2/52	1.8379456792760984E-4	0.0017618927546163977	0	0	132.94666666666666	1143.5662661624315	COL1A1;COL1A2
Solid Neoplasm	4/840	1.8885713615100265E-4	0.0018000783034278424	0	0	22.913875598086126	196.4754782259254	MECOM;CDH1;VIM;VEGFA
Abnormality of pelvic girdle bone morphology	2/53	1.9096402907356786E-4	0.0018098181846290407	0	0	130.33333333333334	1116.0997871835484	COL1A1;COL1A2
Malignant neoplasm of nasopharynx	2/54	1.982691684172618E-4	0.001868434875254196	0	0	127.82051282051282	1089.7829947402583	CDH1;VEGFA
Osteoporosis, Postmenopausal	2/55	2.057099035637798E-4	0.001916894520359691	0	0	125.40251572327044	1064.547425630908	COL1A2;VEGFA
Scoliosis, unspecified	2/55	2.057099035637798E-4	0.001916894520359691	0	0	125.40251572327044	1064.547425630908	COL1A1;COL1A2
Carcinoma, Lobular	2/58	2.2884486091265618E-4	0.002064815176434997	0	0	118.66666666666667	994.7193280076498	CDH1;VEGFA
Heart valve disease	2/58	2.2884486091265618E-4	0.002064815176434997	0	0	118.66666666666667	994.7193280076498	COL1A1;COL1A2
Wide anterior fontanel	2/58	2.2884486091265618E-4	0.002064815176434997	0	0	118.66666666666667	994.7193280076498	COL1A1;COL1A2
Large cell carcinoma of lung	2/58	2.2884486091265618E-4	0.002064815176434997	0	0	118.66666666666667	994.7193280076498	VIM;VEGFA
Congenital aneurysm of ascending aorta	2/58	2.2884486091265618E-4	0.002064815176434997	0	0	118.66666666666667	994.7193280076498	COL1A1;COL1A2
Congestive heart failure	4/884	2.3005334269543055E-4	0.002064815176434997	0	0	21.71818181818182	181.93753863583717	COL1A1;COL1A2;CD68;VEGFA
Hypertrophic Cardiomyopathy	3/328	2.3024917435066517E-4	0.002064815176434997	0	0	36.30830769230769	304.1310375401783	COL1A1;COL1A2;VEGFA
Secondary malignant neoplasm of bone	3/330	2.3441115058084515E-4	0.0020908973217585547	0	0	36.08256880733945	301.5937674244769	CDH1;VIM;VEGFA
Cytokine Measurement	2/59	2.3682715642170133E-4	0.002101211153784031	0	0	116.57894736842105	973.2220345915347	COL1A2;MECOM
Cavernous Hemangioma of Brain	2/60	2.4494463640572313E-4	0.002139843341507746	0	0	114.5632183908046	952.533398651173	VIM;VEGFA
Post-Traumatic Osteoporosis	2/60	2.4494463640572313E-4	0.002139843341507746	0	0	114.5632183908046	952.533398651173	COL1A1;COL1A2
Malignant mesothelioma	3/335	2.450300229184529E-4	0.002139843341507746	0	0	35.53012048192771	295.4020339370646	CDH1;VIM;VEGFA
Cholestasis, Extrahepatic	2/61	2.5319721872997823E-4	0.002188253683117118	0	0	112.61581920903954	932.6100968393627	COL1A1;CD68
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	2/61	2.5319721872997823E-4	0.002188253683117118	0	0	112.61581920903954	932.6100968393627	VIM;VEGFA
Crohn Disease	4/912	2.5946657654129504E-4	0.0022308775756230935	0	0	21.01762114537445	173.54003165503968	COL1A1;CDH1;VIM;VEGFA
Large, late-closing fontanelle	2/63	2.7010736180115496E-4	0.0022754498963854872	0	0	108.91256830601093	894.9009243287231	COL1A1;COL1A2
Wide bregma sutures	2/63	2.7010736180115496E-4	0.0022754498963854872	0	0	108.91256830601093	894.9009243287231	COL1A1;COL1A2
Large bregma sutures	2/63	2.7010736180115496E-4	0.0022754498963854872	0	0	108.91256830601093	894.9009243287231	COL1A1;COL1A2
Large fontanelle	2/63	2.7010736180115496E-4	0.0022754498963854872	0	0	108.91256830601093	894.9009243287231	COL1A1;COL1A2
Osteoporosis, Senile	2/64	2.787647583728535E-4	0.002313331427691142	0	0	107.15053763440861	877.0423971758042	COL1A1;COL1A2
Mitral Valve Prolapse Syndrome	2/64	2.787647583728535E-4	0.002313331427691142	0	0	107.15053763440861	877.0423971758042	COL1A1;COL1A2
Cytogenetically normal acute myeloid leukemia	2/64	2.787647583728535E-4	0.002313331427691142	0	0	107.15053763440861	877.0423971758042	MECOM;CDH1
Skeletal dysplasia	2/66	2.964837911612044E-4	0.0024481928893905396	0	0	103.79166666666667	843.1534732748167	COL1A1;COL1A2
Lymphoma, Follicular	3/359	3.0037021188727E-4	0.0024680665686106712	0	0	33.09438202247191	268.4118134508968	VIM;CD68;VEGFA
Thin skin	2/68	3.1474126366608674E-4	0.00254848751356812	0	0	100.63636363636364	811.5074475931799	COL1A1;COL1A2
Undifferentiated leukemia	2/68	3.1474126366608674E-4	0.00254848751356812	0	0	100.63636363636364	811.5074475931799	MECOM;VEGFA
Osteoarthritis of hip	2/68	3.1474126366608674E-4	0.00254848751356812	0	0	100.63636363636364	811.5074475931799	COL1A1;VEGFA
Squamous cell carcinoma	5/1876	3.17376991791624E-4	0.002557414600523811	0	0	16.141991804739	130.03052753217304	MECOM;CDH1;VIM;CD68;VEGFA
Malignant neoplasm of salivary gland	2/69	3.240717098843516E-4	0.002586371349699036	0	0	99.12935323383084	796.4593227197103	CDH1;VEGFA
Mucoepidermoid Carcinoma	2/69	3.240717098843516E-4	0.002586371349699036	0	0	99.12935323383084	796.4593227197103	CDH1;VEGFA
Nephroblastoma	3/370	3.282331992889992E-4	0.0026071094114954794	0	0	32.084468664850135	257.37474889277485	CDH1;VIM;VEGFA
Idiopathic Pulmonary Fibrosis	3/379	3.5223997431884486E-4	0.002699932728848831	0	0	31.302127659574467	248.88941075527458	COL1A1;VIM;VEGFA
secondary acute myeloid leukemia	2/72	3.528689058087801E-4	0.002699932728848831	0	0	94.86666666666666	754.1344025981498	MECOM;VEGFA
Frequent fractures	2/72	3.528689058087801E-4	0.002699932728848831	0	0	94.86666666666666	754.1344025981498	COL1A1;COL1A2
Hyperuricemia	2/72	3.528689058087801E-4	0.002699932728848831	0	0	94.86666666666666	754.1344025981498	COL1A1;VEGFA
Varying degree of multiple fractures	2/72	3.528689058087801E-4	0.002699932728848831	0	0	94.86666666666666	754.1344025981498	COL1A1;COL1A2
Increased fracture rate	2/72	3.528689058087801E-4	0.002699932728848831	0	0	94.86666666666666	754.1344025981498	COL1A1;COL1A2
Learning Disabilities	2/72	3.528689058087801E-4	0.002699932728848831	0	0	94.86666666666666	754.1344025981498	COL1A1;VEGFA
Rectal Neoplasms	2/72	3.528689058087801E-4	0.002699932728848831	0	0	94.86666666666666	754.1344025981498	CDH1;VEGFA
Fractures, Multiple	2/73	3.6273631743584525E-4	0.002762758801292191	0	0	93.52582159624413	740.8960694909396	COL1A1;COL1A2
Adenoma	4/1000	3.6985338803996703E-4	0.0028041611420484775	0	0	19.072289156626507	150.7169318202462	COL1A2;CDH1;VIM;VEGFA
leukemia	5/1941	3.730817070081043E-4	0.002815838404024968	0	0	15.544077134986226	122.70048544259001	MECOM;CDH1;VIM;CD68;VEGFA
Cardiomyopathy, Familial Idiopathic	3/388	3.773599193069029E-4	0.0028225845085377314	0	0	30.556363636363635	240.85476526953187	CDH1;VIM;VEGFA
Chronic kidney disease stage 5	3/388	3.773599193069029E-4	0.0028225845085377314	0	0	30.556363636363635	240.85476526953187	COL1A1;CD68;VEGFA
Varicosity	2/76	3.931424461075261E-4	0.0029016000004750157	0	0	89.72072072072072	703.5305464332449	COL1A1;VEGFA
Acute Undifferentiated Leukemia	2/76	3.931424461075261E-4	0.0029016000004750157	0	0	89.72072072072072	703.5305464332449	MECOM;VEGFA
Platyspondyly	2/76	3.931424461075261E-4	0.0029016000004750157	0	0	89.72072072072072	703.5305464332449	COL1A1;COL1A2
Squamous cell carcinoma of esophagus	4/1023	4.0358457446289014E-4	0.0029655465647757742	0	0	18.619234543670267	145.51163586876643	MECOM;CDH1;VIM;VEGFA
Acute monocytic leukemia	2/78	4.140822931136557E-4	0.003016110327133527	0	0	87.35087719298245	680.4149259453243	MECOM;VEGFA
Cerebral arterial aneurysm	2/78	4.140822931136557E-4	0.003016110327133527	0	0	87.35087719298245	680.4149259453243	COL1A2;CD68
Malignant tumor of colon	5/2001	4.309732254374044E-4	0.00312549278273735	0	0	15.026720106880427	116.44903539833481	MECOM;CDH1;VIM;CD68;VEGFA
Extrahepatic Cholangiocarcinoma	2/80	4.3555665366191277E-4	0.0031450584342340715	0	0	85.1025641025641	658.5990147800662	CDH1;VEGFA
Neoplasms, Experimental	2/81	4.4649407260485916E-4	0.003196361000450236	0	0	84.0210970464135	648.145836767381	CDH1;VEGFA
Connective Tissue Diseases	2/81	4.4649407260485916E-4	0.003196361000450236	0	0	84.0210970464135	648.145836767381	COL1A1;COL1A2
Malignant neoplasm of ovary	5/2026	4.570523838843243E-4	0.0032477370712333704	0	0	14.820221012699983	113.97805970756659	MECOM;CDH1;VIM;CD68;VEGFA
Osteoporosis, Age-Related	2/82	4.575648751437902E-4	0.0032477370712333704	0	0	82.96666666666667	637.9798062865145	COL1A1;COL1A2
Colorectal Neoplasms	4/1073	4.8455658106787315E-4	0.003424747361106832	0	0	17.70159027128157	135.10342880369424	COL1A2;CDH1;VIM;VEGFA
Cicatrix, Hypertrophic	2/85	4.915767701450155E-4	0.003445168288243218	0	0	79.95582329317268	609.0948613959647	COL1A2;VIM
Increased tendency to bruise	2/85	4.915767701450155E-4	0.003445168288243218	0	0	79.95582329317268	609.0948613959647	COL1A1;COL1A2
Inflammation	3/429	5.064993667177108E-4	0.0035348993459629356	0	0	27.557746478873238	209.1078353851077	CDH1;CD68;VEGFA
Triangular face	2/87	5.149167919037894E-4	0.0035786717037313365	0	0	78.06666666666666	591.0821756948658	COL1A1;COL1A2
Kidney Failure, Chronic	3/437	5.346234507570942E-4	0.0036983499646757122	0	0	27.038709677419355	203.70822970179663	COL1A1;CD68;VEGFA
Meningioma	3/438	5.382083785193903E-4	0.0036983499646757122	0	0	26.975172413793103	203.04926449280617	CDH1;CD68;VEGFA
Osteoarthrosis Deformans	2/89	5.387883941344113E-4	0.0036983499646757122	0	0	76.26436781609195	573.9799434877386	COL1A2;VIM
Osteoporosis	3/441	5.490564246817181E-4	0.0037533857228242043	0	0	26.786301369863015	201.09305057958173	COL1A1;COL1A2;MECOM
Childhood Acute Lymphoblastic Leukemia	3/443	5.56366468450267E-4	0.003787833752551206	0	0	26.66181818181818	199.805888114817	COL1A1;MECOM;VEGFA
Prolactinoma	2/91	5.631909264757575E-4	0.0038187092087868437	0	0	74.54307116104869	557.7231976308009	CDH1;VEGFA
Precancerous Conditions	3/446	5.67449139436615E-4	0.003832004714899894	0	0	26.477200902934538	197.90011637496798	CDH1;VIM;VEGFA
Small for gestational age (disorder)	2/93	5.881237389662702E-4	0.003908328273289796	0	0	72.8974358974359	542.2529124166269	COL1A1;COL1A2
PARKINSON DISEASE, LATE-ONSET	2/93	5.881237389662702E-4	0.003908328273289796	0	0	72.8974358974359	542.2529124166269	COL1A1;VEGFA
Joint laxity	2/93	5.881237389662702E-4	0.003908328273289796	0	0	72.8974358974359	542.2529124166269	COL1A1;COL1A2
Low Birth Weights	2/93	5.881237389662702E-4	0.003908328273289796	0	0	72.8974358974359	542.2529124166269	COL1A1;COL1A2
Eczema	3/454	5.976984477722023E-4	0.003946362015157672	0	0	25.99689578713969	192.95998839295876	CDH1;CD68;VEGFA
Atherosclerosis	4/1134	5.98578890788304E-4	0.003946362015157672	0	0	16.69203539823009	123.8707972695094	CDH1;VIM;CD68;VEGFA
Congenital diaphragmatic hernia	2/95	6.135861820645458E-4	0.004029376975132529	0	0	71.3225806451613	527.5153454470864	COL1A1;VEGFA
Malignant neoplasm of urinary bladder	4/1144	6.189705225967616E-4	0.00404879541839764	0	0	16.53684210526316	122.16514229007909	COL1A2;CDH1;VIM;VEGFA
Steroid Sulfatase Deficiency Disease	2/96	6.265158123586112E-4	0.004082142089899076	0	0	70.56028368794327	520.4058388914005	VIM;VEGFA
Carcinoma of bladder	4/1162	6.569357469803837E-4	0.00426369192981821	0	0	16.264248704663213	119.18318398491296	COL1A2;CDH1;VIM;VEGFA
Ovarian Carcinoma	5/2203	6.784861925089719E-4	0.004376440224063723	0	0	13.492569002123142	98.4370128572969	MECOM;CDH1;VIM;CD68;VEGFA
Rhinitis	2/100	6.795551666861537E-4	0.004376440224063723	0	0	67.66666666666667	493.5655481733249	CD68;VEGFA
Mammary Neoplasms, Human	3/476	6.8620559567417E-4	0.004379414926857674	0	0	24.75983086680761	180.35885981672052	MECOM;CDH1;VIM
Lung Neoplasms	4/1177	6.898370620582995E-4	0.004379414926857674	0	0	16.043478260869566	116.78136274108871	CDH1;VIM;CD68;VEGFA
Glioma	5/2211	6.901510992571731E-4	0.004379414926857674	0	0	13.437594439407675	97.80687488554226	COL1A1;MECOM;CDH1;VIM;VEGFA
Hypertension, Portal	2/101	6.931448085674015E-4	0.004379414926857674	0	0	66.97979797979798	487.22924366705774	COL1A2;VEGFA
Hematocrit procedure	2/101	6.931448085674015E-4	0.004379414926857674	0	0	66.97979797979798	487.22924366705774	MECOM;VEGFA
Adult Acute Myeloblastic Leukemia	2/102	7.068662099163871E-4	0.004432529466693736	0	0	66.30666666666667	481.03292886084796	MECOM;VEGFA
Childhood Acute Myeloid Leukemia	2/102	7.068662099163871E-4	0.004432529466693736	0	0	66.30666666666667	481.03292886084796	MECOM;VEGFA
Ichthyosis, X-Linked	2/103	7.207192897761812E-4	0.004502471068714121	0	0	65.64686468646865	474.9721887477784	VIM;VEGFA
Acquired flat foot	2/104	7.347039673000961E-4	0.004572709766628957	0	0	65.0	469.0427888549896	COL1A1;COL1A2
Biliary Atresia	2/105	7.488201616434291E-4	0.0046260445541527395	0	0	64.36569579288026	463.2406662079546	CD68;VEGFA
Ehlers-Danlos Syndrome	2/105	7.488201616434291E-4	0.0046260445541527395	0	0	64.36569579288026	463.2406662079546	COL1A1;COL1A2
Infection	3/492	7.556102558485682E-4	0.004650767183599306	0	0	23.93006134969325	172.00891842465938	CDH1;VIM;VEGFA
Head and Neck Neoplasms	2/107	7.774467777360754E-4	0.00473730382419711	0	0	63.13333333333333	452.0028076501448	VIM;VEGFA
Primary malignant neoplasm of lung	5/2268	7.778120748965585E-4	0.00473730382419711	0	0	13.0571512741199	93.4764803903952	NFASC;CDH1;VIM;CD68;VEGFA
Pneumonia	3/497	7.781901965407722E-4	0.00473730382419711	0	0	23.68178137651822	169.52696966635597	VIM;CD68;VEGFA
Bladder Neoplasm	4/1217	7.833865372383922E-4	0.004751595433140503	0	0	15.481450948062655	110.72154631605117	COL1A2;CDH1;VIM;VEGFA
Adult T-Cell Lymphoma/Leukemia	3/500	7.919445047989284E-4	0.004751742227669341	0	0	23.535211267605632	168.06539643950128	VIM;CD68;VEGFA
Flatfoot	2/108	7.919570379448901E-4	0.004751742227669341	0	0	62.534591194968556	446.5597291313328	COL1A1;COL1A2
Severe myopia	2/108	7.919570379448901E-4	0.004751742227669341	0	0	62.534591194968556	446.5597291313328	COL1A1;VEGFA
Myeloid Leukemia	3/501	7.965638320569233E-4	0.004762252587351069	0	0	23.486746987951808	167.58271440657347	MECOM;VIM;VEGFA
Herpes Simplex Infections	3/503	8.058544900832821E-4	0.0048005903194961235	0	0	23.3904	166.62402571383245	VIM;CD68;VEGFA
Secondary malignant neoplasm of liver	3/508	8.293857822917274E-4	0.004923186778870467	0	0	23.15287128712871	164.26557355958622	VIM;CD68;VEGFA
Merkel cell carcinoma	2/112	8.513092103094032E-4	0.005035403414170513	0	0	60.24848484848485	425.88058234303134	CD68;VEGFA
Diabetes Mellitus, Experimental	2/113	8.664746331823843E-4	0.00507115680052006	0	0	59.7027027027027	420.96839710585425	CD68;VEGFA
Streptozotocin Diabetes	2/113	8.664746331823843E-4	0.00507115680052006	0	0	59.7027027027027	420.96839710585425	CD68;VEGFA
Alloxan Diabetes	2/113	8.664746331823843E-4	0.00507115680052006	0	0	59.7027027027027	420.96839710585425	CD68;VEGFA
Urticaria	2/114	8.817708468325254E-4	0.005106922821238377	0	0	59.166666666666664	416.1533855048973	CD68;VEGFA
Intracranial Aneurysm	2/114	8.817708468325254E-4	0.005106922821238377	0	0	59.166666666666664	416.1533855048973	COL1A2;VEGFA
Joint hyperflexibility	2/114	8.817708468325254E-4	0.005106922821238377	0	0	59.166666666666664	416.1533855048973	COL1A1;COL1A2
Condition, Preneoplastic	2/116	9.127553241873193E-4	0.005268082632333732	0	0	58.12280701754386	406.80400841061345	CDH1;VEGFA
Polycystic Ovary Syndrome	3/526	9.177495110270215E-4	0.005278642015148524	0	0	22.335372848948374	156.20435238854242	VIM;CD68;VEGFA
Red Blood Cell Count measurement	2/118	9.442619982927832E-4	0.005412470835575129	0	0	57.11494252873563	397.8116797152368	MECOM;VEGFA
Hypodontia	2/121	9.924997219719256E-4	0.005669484713182096	0	0	55.666666666666664	384.9507996212819	COL1A2;CDH1
Gastrointestinal Neoplasms	2/122	0.001008839365030631	0.005723619254663579	0	0	55.2	380.822302334395	CDH1;VEGFA
Pilocytic Astrocytoma	2/122	0.001008839365030631	0.005723619254663579	0	0	55.2	380.822302334395	COL1A1;VEGFA
Hyperplasia	2/123	0.0010253090751746587	0.0057866656128150494	0	0	54.74104683195592	376.7695518187188	CDH1;VEGFA
Lymphoma	4/1307	0.0010268903005954764	0.0057866656128150494	0	0	14.343054489639293	98.69771584103515	CDH1;VIM;CD68;VEGFA
Multiple Myeloma	4/1312	0.001041839236931307	0.005809353230094248	0	0	14.284403669724771	98.08768074353495	COL1A1;CDH1;CD68;VEGFA
Hernia, Inguinal	2/124	0.0010419087722074684	0.005809353230094248	0	0	54.2896174863388	372.79056471925674	COL1A1;COL1A2
Uterine Cervical Neoplasm	2/124	0.0010419087722074684	0.005809353230094248	0	0	54.2896174863388	372.79056471925674	CDH1;VEGFA
Asthma	4/1313	0.0010448477032543612	0.005809353230094248	0	0	14.272727272727273	97.96634640033778	COL1A1;CDH1;CD68;VEGFA
Hematologic Neoplasms	3/557	0.0010836994446275173	0.006005351075211625	0	0	21.051985559566788	143.72979316287064	MECOM;CDH1;VEGFA
Gastritis, Atrophic	2/127	0.0010924869820753854	0.0060140867528110315	0	0	52.97866666666667	361.2773446106595	CDH1;VEGFA
Childhood asthma	2/127	0.0010924869820753854	0.0060140867528110315	0	0	52.97866666666667	361.2773446106595	CDH1;VEGFA
Ependymoma	2/128	0.0011096058245021485	0.006048439592384261	0	0	52.55555555555556	357.57488422434	MECOM;VEGFA
Biliary Tract Cancer	2/128	0.0011096058245021485	0.006048439592384261	0	0	52.55555555555556	357.57488422434	CDH1;VEGFA
Peritonitis	2/128	0.0011096058245021485	0.006048439592384261	0	0	52.55555555555556	357.57488422434	CD68;VEGFA
Malignant neoplasm of lung	5/2449	0.0011140998741744027	0.006053155016686983	0	0	11.966721222040372	81.37021586510193	NFASC;CDH1;VIM;CD68;VEGFA
Renal Cell Carcinoma	4/1348	0.001154132692412331	0.006250303022544702	0	0	13.875	93.8561350918658	CDH1;VIM;CD68;VEGFA
Juvenile rheumatoid arthritis	2/131	0.0011617395476570577	0.006250908275780556	0	0	51.325581395348834	346.8499020731412	VIM;VEGFA
Neoplastic Cell Transformation	2/131	0.0011617395476570577	0.006250908275780556	0	0	51.325581395348834	346.8499020731412	CDH1;VIM
Carcinoma of lung	5/2476	0.0011725501119338958	0.00628878966786411	0	0	11.817752596789424	79.75298168497275	NFASC;CDH1;VIM;CD68;VEGFA
Diffuse Large B-Cell Lymphoma	3/575	0.0011883151899119118	0.006352915822990605	0	0	20.37062937062937	137.2006455353079	CDH1;VIM;VEGFA
PACHYONYCHIA CONGENITA 3	2/133	0.0011971422260689164	0.006379658891638827	0	0	50.536895674300254	340.003038438211	VIM;VEGFA
Thyroid Gland Follicular Adenoma	2/134	0.0012150373843230172	0.006454402410989785	0	0	50.15151515151515	336.66613993116835	CD68;VEGFA
Motor Neuron Disease	2/135	0.0012330616485366672	0.006529355015108447	0	0	49.771929824561404	333.3850806557954	VIM;VEGFA
Hodgkin Disease	3/592	0.0012928612437237608	0.006824343526997572	0	0	19.765365025466892	131.45741680263535	VIM;CD68;VEGFA
Acid reflux	2/140	0.001325116765595537	0.006972538690893867	0	0	47.95652173913044	317.77212749518304	COL1A1;COL1A2
Pectus excavatum	2/141	0.0013439139896361195	0.007049209228657382	0	0	47.60911270983213	314.7995008311823	COL1A1;COL1A2
Lymphatic Metastasis	2/142	0.0013628397612813203	0.007126071228267218	0	0	47.266666666666666	311.874196651513	CDH1;VEGFA
Liver diseases	3/606	0.0013832376640857344	0.007210126324046891	0	0	19.292537313432835	127.00910869344945	COL1A2;CD68;VEGFA
Generalized osteopenia	2/145	0.001420387564134151	0.007357784027875043	0	0	46.26806526806527	303.37163074605706	COL1A1;COL1A2
Nerve Degeneration	2/145	0.001420387564134151	0.007357784027875043	0	0	46.26806526806527	303.37163074605706	CDH1;VEGFA
Monoclonal Gammopathy of Undetermined Significance	2/150	0.0015188640882368835	0.007843545817892018	0	0	44.693693693693696	290.05279964440666	CDH1;VEGFA
Pulmonary Hypertension	2/151	0.0015389432054551456	0.007922707613269082	0	0	44.391498881431765	287.50861532960903	COL1A1;VEGFA
Conventional (Clear Cell) Renal Cell Carcinoma	3/631	0.0015544685383883134	0.007978010837020636	0	0	18.500636942675158	119.63661787016643	CDH1;VIM;VEGFA
Triple Negative Breast Neoplasms	3/632	0.001561584610642016	0.007989948253223567	0	0	18.47027027027027	119.35588752377888	CDH1;VIM;VEGFA
Familial lichen amyloidosis	2/153	0.0015794846162693692	0.008032257133955206	0	0	43.799116997792495	282.53306652560025	CDH1;VEGFA
Cachexia	2/153	0.0015794846162693692	0.008032257133955206	0	0	43.799116997792495	282.53306652560025	CD68;VEGFA
Breast Cancer, Familial	2/154	0.0015999467516310945	0.008111584138968588	0	0	43.50877192982456	280.1001162752895	CDH1;VEGFA
Hyperkyphosis	2/157	0.0016620979247651978	0.008380179584389316	0	0	42.660215053763444	273.0114974595554	COL1A1;COL1A2
Brain Neoplasms	3/646	0.0016633992711894252	0.008380179584389316	0	0	18.055054432348367	115.5323436677846	CDH1;VIM;VEGFA
Small midface	2/158	0.0016830696407496527	0.008380179584389316	0	0	42.38461538461539	270.7163021628483	COL1A1;COL1A2
Hypotrophic midface	2/158	0.0016830696407496527	0.008380179584389316	0	0	42.38461538461539	270.7163021628483	COL1A1;COL1A2
Midface retrusion	2/158	0.0016830696407496527	0.008380179584389316	0	0	42.38461538461539	270.7163021628483	COL1A1;COL1A2
Decreased projection of midface	2/158	0.0016830696407496527	0.008380179584389316	0	0	42.38461538461539	270.7163021628483	COL1A1;COL1A2
Sporadic Breast Carcinoma	2/159	0.0017041685538346414	0.008459979606536256	0	0	42.11252653927813	268.45379388116373	CDH1;VEGFA
Hypotrophic malar bone	2/160	0.001725394584626806	0.008514669133602108	0	0	41.84388185654009	266.22330903009095	COL1A1;COL1A2
Malar flattening	2/160	0.001725394584626806	0.008514669133602108	0	0	41.84388185654009	266.22330903009095	COL1A1;COL1A2
Familial multiple trichoepitheliomata	2/161	0.0017467476545246084	0.008594616778014886	0	0	41.57861635220126	264.0242015000183	CDH1;VEGFA
Sarcoma	3/658	0.0017539562639708355	0.008604703083245159	0	0	17.713282442748092	112.40638817579077	COL1A1;VIM;VEGFA
Anaplastic astrocytoma	2/166	0.001855415818156856	0.009075758312861103	0	0	40.300813008130085	253.47786536035218	VIM;VEGFA
Small cell carcinoma of lung	3/673	0.0018714861456131872	0.009127599096148527	0	0	17.303283582089552	108.68231235183393	CDH1;VIM;VEGFA
Irritable Bowel Syndrome	2/167	0.001877529460569706	0.009130376502129067	0	0	40.054545454545455	251.45436469448734	CDH1;CD68
Kyphosis deformity of spine	2/168	0.0018997695891275785	0.0091849729700429	0	0	39.81124497991968	249.45816352702607	COL1A1;COL1A2
Breast adenocarcinoma	2/168	0.0018997695891275785	0.0091849729700429	0	0	39.81124497991968	249.45816352702607	CDH1;VEGFA
Papillary Renal Cell Carcinoma	2/169	0.0019221361241047513	0.009239547708953098	0	0	39.57085828343313	247.48873704438736	CDH1;VEGFA
Cyst	2/169	0.0019221361241047513	0.009239547708953098	0	0	39.57085828343313	247.48873704438736	CDH1;VEGFA
Respiratory function loss	2/170	0.0019446289871887304	0.009320807904111501	0	0	39.333333333333336	245.54557350634758	COL1A1;COL1A2
Prostatic Neoplasms	4/1554	0.001970088560048347	0.009415781427394394	0	0	11.898064516129033	74.12109627761573	CDH1;VIM;CD68;VEGFA
Prostatic Intraepithelial Neoplasias	2/174	0.002035862143008843	0.009702337298682143	0	0	38.41085271317829	238.02575074713616	CDH1;VIM
Well Differentiated Oligodendroglioma	2/176	0.0020822346407219647	0.009839001078538917	0	0	37.96551724137931	234.41101002162543	CDH1;VEGFA
Mucosa-Associated Lymphoid Tissue Lymphoma	2/176	0.0020822346407219647	0.009839001078538917	0	0	37.96551724137931	234.41101002162543	CDH1;VIM
Carcinomatosis	2/176	0.0020822346407219647	0.009839001078538917	0	0	37.96551724137931	234.41101002162543	CDH1;VEGFA
Dengue Fever	2/177	0.002105609594064709	0.009921346900847273	0	0	37.74666666666667	232.6383784955949	VIM;VEGFA
Scleroderma	2/179	0.0021527365166767467	0.010114829605117785	0	0	37.31638418079096	229.16049170690178	COL1A1;COL1A2
Respiratory Insufficiency	2/182	0.0022243682619392407	0.010281822006868592	0	0	36.68888888888889	224.1060917402512	COL1A1;COL1A2
Nephrotic Syndrome	2/182	0.0022243682619392407	0.010281822006868592	0	0	36.68888888888889	224.1060917402512	COL1A1;VEGFA
Hepatitis, Chronic	2/183	0.002248496226181967	0.010281822006868592	0	0	36.484346224677715	222.46306870429467	CDH1;CD68
Neoplasm Invasiveness	2/183	0.002248496226181967	0.010281822006868592	0	0	36.484346224677715	222.46306870429467	CDH1;VIM
oligodendroglioma	2/183	0.002248496226181967	0.010281822006868592	0	0	36.484346224677715	222.46306870429467	CDH1;VEGFA
Ulcer	2/184	0.0022727494173886338	0.010281822006868592	0	0	36.282051282051285	220.8403192662031	CDH1;VEGFA
Leukemogenesis	3/730	0.0023633608901539134	0.010281822006868592	0	0	15.89958734525447	96.15546641572969	MECOM;CDH1;VEGFA
B-Cell Lymphomas	3/730	0.0023633608901539134	0.010281822006868592	0	0	15.89958734525447	96.15546641572969	CDH1;VIM;VEGFA
Carcinoma, Spindle-Cell	2/188	0.002371012885390744	0.010281822006868592	0	0	35.494623655913976	214.5450533466253	CDH1;VIM
Familial Alzheimer Disease (FAD)	2/188	0.002371012885390744	0.010281822006868592	0	0	35.494623655913976	214.5450533466253	VIM;VEGFA
Anoxia-Ischemia, Brain	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Epithelial tumor of ovary	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VIM
Anoxia-Ischemia, Cerebral	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Renal cancer metastatic	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Erythrocytosis due to low atmospheric pressure	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Exudative age-related macular degeneration	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Dissection, Blood Vessel	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	COL1A1
EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	COL1A2
Vitreoretinopathy	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Kaposi's sarcoma-associated herpesvirus infection	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Anoxic-Ischemic Encephalopathy	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Bat ear	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	COL1A1
Microcystic stromal tumor	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VIM
Carcinomatous ascites	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Central blindness	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Cerebral Hypoxia-Ischemia	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Chagas' disease without mention of organ involvement	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VIM
Cigarette-paper scars	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	COL1A1
Ovarian papillary adenocarcinoma	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	CDH1
Papillary transitional cell carcinoma	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Craniofacial disproportion	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	COL1A1
Pilomyxoid astrocytoma	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	COL1A1
Posterior polar cataract	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VIM
prenatal alcohol exposure	1/6	0.002397858969227747	0.010281822006868592	0	0	571.0571428571428	3445.2899826083253	VEGFA
Astrocytoma	3/741	0.00246677023463729	0.010550186541987179	0	0	15.653658536585366	93.9978022946944	CDH1;VIM;VEGFA
Disseminated Malignant Neoplasm	2/195	0.002547777103680094	0.010749818122606529	0	0	34.19516407599309	204.23178090119762	VIM;VEGFA
Carcinoma, Papillary	2/196	0.00257352691224081	0.010749818122606529	0	0	34.017182130584196	202.82669944556145	CDH1;VEGFA
Tuberous Sclerosis	2/197	0.0025994009309190567	0.010749818122606529	0	0	33.84102564102564	201.43783445575303	VIM;VEGFA
Aplasia Cutis Congenita	2/199	0.0026515212863605225	0.010749818122606529	0	0	33.49407783417936	198.70769409839338	VIM;VEGFA
Renal fibrosis	2/202	0.002730631445843234	0.010749818122606529	0	0	32.986666666666665	194.72762949170337	VIM;VEGFA
Leukemia, Myelocytic, Acute	4/1703	0.002771508392377243	0.010749818122606529	0	0	10.766921718658034	63.39954951238977	MECOM;CDH1;VIM;VEGFA
Anaplastic carcinoma	2/204	0.0027839903939959804	0.010749818122606529	0	0	32.65676567656766	192.14816343516293	CDH1;VEGFA
Osteogenesis Imperfecta	2/204	0.0027839903939959804	0.010749818122606529	0	0	32.65676567656766	192.14816343516293	COL1A1;COL1A2
Abortion, Habitual	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Enlargement of calvarial bones	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	COL1A1
Chondromatosis, Synovial	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Familial Motor Neuron Disease	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VIM
Fenestration (morphologic abnormality)	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Sclerosteosis	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	COL1A1
Sertoli-Leydig Cell Tumor	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VIM
GIANT AXONAL NEUROPATHY 1	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VIM
Hemangioma of retina	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Synovial osteochondromatosis	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Ulcer of esophagus	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Idiopathic osteoporosis	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	COL1A1
In situ cancer	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Increased ossification of calvarial bones	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	COL1A1
Infantile myofibromatosis	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VIM
Waardenburg Anophthalmia Syndrome	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	CD68
Intermenstrual heavy bleeding	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Adult Classical Hodgkin Lymphoma	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
LEPTIN DEFICIENCY OR DYSFUNCTION	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Angiodysplasia	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Angiodysplasia of colon	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Angiokeratoma	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Anterior Horn Cell Disease	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VIM
Limited pronation/supination of forearm	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	MECOM
Lymphangiectasis	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Malignant neoplasm of appendix	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Meningeal Neoplasms	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Bowel diverticula	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	COL1A1
Bowel diverticulosis	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	COL1A1
Molluscoid pseudotumors	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	COL1A1
Calvarial hyperostosis	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	COL1A1
Chromosome 17 trisomy	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Cohen syndrome	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
OTOFACIOCERVICAL SYNDROME 1	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	CDH1
Deficiency of butyryl-CoA dehydrogenase	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Primary malignant neoplasm of appendix	1/7	0.002797015027105056	0.010749818122606529	0	0	475.85714285714283	2797.6605002155425	VEGFA
Squamous cell carcinoma of skin	2/205	0.0028108552869307766	0.010778176134713874	0	0	32.49425287356322	190.87990010257073	VIM;VEGFA
Adenocarcinoma	4/1712	0.0028262861514055265	0.010812489221432152	0	0	10.704918032786885	62.82493456198209	CDH1;VIM;CD68;VEGFA
Colonic Neoplasms	3/778	0.0028354401194812897	0.010822686771841629	0	0	14.87767741935484	87.265881428468	MECOM;CDH1;VEGFA
Polycythemia Vera	2/207	0.0028649555222551525	0.010910378564204553	0	0	32.1739837398374	188.38518853089187	MECOM;VEGFA
Hepatitis C	3/783	0.0028877643604832146	0.010964032051159445	0	0	14.778461538461539	86.41369402071992	VIM;CD68;VEGFA
Colorectal cancer metastatic	2/208	0.002892190708938942	0.010964032051159445	0	0	32.016181229773466	187.15830434264055	CDH1;VEGFA
Myxoid cyst	2/209	0.0029195491709734464	0.011042648565042423	0	0	31.85990338164251	185.94478463419517	CD68;VEGFA
Blast Phase	2/214	0.003058187902747564	0.011342512117730375	0	0	31.10062893081761	180.07054927916843	MECOM;CDH1
Frontal bossing	2/216	0.0031145036099737853	0.011342512117730375	0	0	30.806853582554517	177.80746994389892	COL1A1;COL1A2
Invasive Ductal Breast Carcinoma	2/218	0.003171309938319217	0.011342512117730375	0	0	30.51851851851852	175.59167001765948	CDH1;VEGFA
Epidermolysis Bullosa Dystrophica	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	COL1A1
Erdheim-Chester Disease	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	CD68
Retinal Neovascularization	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Fetal Hypoxia	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Secondary malignant neoplasm of ovary	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	CDH1
Motor Neuron Disease, Upper	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VIM
Multiple Sclerosis, Secondary Progressive	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Squamous cell carcinoma of lip	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	CD68
Supratentorial Neoplasms	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VIM
Visually threatening diabetic retinopathy	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Intestinal adenocarcinoma	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	CDH1
Adult Fibrosarcoma	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	COL1A1
Krukenberg Tumor	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	CDH1
Altitude Sickness	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Apocrine Carcinoma	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	CDH1
Macular Holes	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Avascular retina	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Melanoma recurrent	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Myofibromatosis	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VIM
Claudication (finding)	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Cleft palate and bilateral cleft lip	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	CDH1
Congenital atresia of extrahepatic bile duct	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Cranial asymmetry	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	COL1A1
Poxviridae Infections	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Distichiasis	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	CDH1
Ectopic Pregnancy	1/8	0.0031960315919264243	0.011342512117730375	0	0	407.85714285714283	2343.4840743955892	VEGFA
Gastrointestinal Carcinoid Tumor	2/225	0.00337398679315392	0.011933412108086745	0	0	29.550074738415546	168.18898456650322	CD68;VEGFA
Ki-1+ Anaplastic Large Cell Lymphoma	2/228	0.003462679240235197	0.011933412108086745	0	0	29.153392330383483	165.17474350313532	CD68;VEGFA
Stomach Neoplasms	3/835	0.0034682515894098372	0.011933412108086745	0	0	13.817307692307692	78.26267711980697	CDH1;VIM;VEGFA
Endometrioma	2/229	0.0034924869486352393	0.011933412108086745	0	0	29.023494860499266	164.19000865387758	CD68;VEGFA
Ductal Carcinoma	2/230	0.003522416307797602	0.011933412108086745	0	0	28.894736842105264	163.21504381644107	CDH1;VEGFA
Hyperlipidemia	2/232	0.0035826396715068296	0.011933412108086745	0	0	28.640579710144927	161.29387572345155	CD68;VEGFA
Metastasis from malignant tumor of prostate	2/232	0.0035826396715068296	0.011933412108086745	0	0	28.640579710144927	161.29387572345155	CDH1;VEGFA
Renal vascular disorder	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Hypoxia-Ischemia, Brain	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Keratitis, Herpetic	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Glycogen Storage Disease Type IV	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	COL1A2
Spinal Cord Contusion	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Spinal Cord Injuries	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Spinal Cord Laceration	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Spinal Cord transection injury	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Hemorrhagic cystitis	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Venous retinal branch occlusion	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Wide cranial sutures	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	COL1A1
Langer-Giedion Syndrome	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VIM
Lung cancer stage I	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Magnesium measurement	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	MECOM
Bronchial carcinoid	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Calcaneovalgus deformity	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	COL1A2
Capillary Leak Syndrome	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Myocardial hypoxia	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Nephrogenic Fibrosing Dermopathy	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	COL1A1
Chronic acquired lymphedema	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Chronic periaortitis	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Collagen-vascular disease	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Pericytic Neoplasm	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Post-Traumatic Myelopathy	1/9	0.003594908666217628	0.011933412108086745	0	0	356.85714285714283	2008.4764659134423	VEGFA
Gallbladder Carcinoma	2/233	0.003612933521932738	0.011933412108086745	0	0	28.515151515151516	160.34740449390065	VIM;VEGFA
Hamman-Rich syndrome	2/233	0.003612933521932738	0.011933412108086745	0	0	28.515151515151516	160.34740449390065	VIM;VEGFA
Chronic myeloproliferative disorder	2/233	0.003612933521932738	0.011933412108086745	0	0	28.515151515151516	160.34740449390065	MECOM;VEGFA
Promyelocytic leukemia	2/233	0.003612933521932738	0.011933412108086745	0	0	28.515151515151516	160.34740449390065	MECOM;VIM
Tumor Initiation	2/234	0.0036433487154574028	0.01201009023198211	0	0	28.39080459770115	159.410167211408	CDH1;VEGFA
Plaque, Amyloid	2/235	0.0036738851749145785	0.012086864835813643	0	0	28.267525035765377	158.4820358876279	VIM;CD68
Malignant neoplasm of pancreas	4/1846	0.003735236736325493	0.012216698832059636	0	0	9.853420195439739	55.08006788123319	CDH1;VIM;CD68;VEGFA
Undifferentiated carcinoma	2/237	0.003735321585341975	0.012216698832059636	0	0	28.024113475177305	156.65259061114202	CDH1;VEGFA
IGA Glomerulonephritis	2/237	0.003735321585341975	0.012216698832059636	0	0	28.024113475177305	156.65259061114202	CD68;VEGFA
Endometrial Neoplasms	2/238	0.0037662213824331088	0.01229365414070142	0	0	27.903954802259886	155.7510319934582	CDH1;VEGFA
Hypercholesterolemia	2/240	0.003828383775873612	0.012472156519838252	0	0	27.666666666666668	153.97364736845176	CD68;VEGFA
Chondrosarcoma	2/241	0.003859646218995797	0.012549492969366452	0	0	27.549511854951184	153.09758948029074	CD68;VEGFA
Pancreatic carcinoma	4/1869	0.00390965421459325	0.012568682950784386	0	0	9.719571045576407	53.88827941926026	CDH1;VIM;CD68;VEGFA
Virus Diseases	3/875	0.003961070003225909	0.012568682950784386	0	0	13.155963302752294	72.76880476423558	CDH1;CD68;VEGFA
Scimitar Syndrome	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Seropositive rheumatoid arthritis	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VIM
Sex hormone binding globulin measurement	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	CD68
Gangrene	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Kabuki syndrome eyelids	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	CDH1
Amegakaryocytic thrombocytopenia	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	MECOM
Leukostasis	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Liver mass	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Lymphangioma	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Bone marrow myeloid dysplasia	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	MECOM
Congenital euryblepharon	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	CDH1
Denys-Drash Syndrome	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Pressure Ulcer	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Primary bacterial peritonitis	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Prostatic Adenoma	1/10	0.0039936462613403625	0.012568682950784386	0	0	317.1904761904762	1751.8590547314027	VEGFA
Malignant neoplasm of prostate	5/3239	0.004038674449470551	0.012678427287824269	0	0	8.636363636363637	47.60224372767077	MECOM;CDH1;VIM;CD68;VEGFA
Splenomegaly	2/247	0.004049753493788047	0.012678427287824269	0	0	26.866666666666667	148.01113359835426	MECOM;VEGFA
Breast Carcinoma	6/4963	0.004051319990653678	0.012678427287824269	0	0	9.099253580794835	50.125172190032124	COL1A1;MECOM;CDH1;VIM;CD68;VEGFA
Malignant tumor of cervix	3/884	0.004077647030677269	0.01273691993852001	0	0	13.015437003405221	71.61399516919566	CDH1;VIM;VEGFA
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	2/249	0.0041140855531755435	0.012826719070461321	0	0	26.64642375168691	146.377830607865	MECOM;CDH1
Skin Neoplasms	2/256	0.004343027400705629	0.013059293498752119	0	0	25.902887139107612	140.89055934148473	COL1A1;VEGFA
Colorectal Cancer	5/3298	0.0043832117188084135	0.013059293498752119	0	0	8.451766373114689	45.89286789203524	MECOM;CDH1;VIM;CD68;VEGFA
Eosinophilia-Myalgia Syndrome	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	COL1A1
Refractory Cytopenia of Childhood	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Erosive esophagitis	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Colitis, Ischemic	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Rotator cuff syndrome	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Hernia, Femoral	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	COL1A1
Sinonasal undifferentiated carcinoma	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Granular cell tumor	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	CD68
Sturge-Weber Syndrome	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Subcutaneous hemorrhage	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	COL1A2
High Grade Ovarian Serous Adenocarcinoma	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	CD68
Yersinia infections	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Angioma	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Leukemic Infiltration	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Lipoblastoma	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	COL1A2
Bilateral pheochromocytoma and islet cell adenoma of the pancreas	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Burn scar	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Nasopharyngeal Angiofibroma	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Non-Hereditary Clear Cell Renal Cell Carcinoma	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Nonproliferative diabetic retinopathy	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Peripheral Nerve Sheath Neoplasm	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Diabetic macular edema	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VEGFA
Pseudomonas Infections	1/11	0.004392244396163033	0.013059293498752119	0	0	285.45714285714286	1549.43708775113	VIM
Malignant neoplasm of breast	6/5054	0.004473873175097508	0.013262477708638783	0	0	8.881141045958795	48.042539268073675	COL1A1;MECOM;CDH1;VIM;CD68;VEGFA
Hearing Loss, Partial	2/260	0.0044764837829518195	0.013262477708638783	0	0	25.496124031007753	137.906429174229	COL1A1;COL1A2
Ulcerative Colitis	3/915	0.004495509827304765	0.013295231191390687	0	0	12.552631578947368	67.84290909830035	CDH1;CD68;VEGFA
Endothelial dysfunction	2/262	0.004543927938262681	0.013414640355791417	0	0	25.297435897435896	136.45344477002513	VIM;VEGFA
Malignant neoplasm of gastrointestinal tract	2/263	0.004577828740727042	0.013490845122849305	0	0	25.199233716475096	135.73644016745862	CDH1;VEGFA
Myeloproliferative disease	2/264	0.004611848591250575	0.013543886033581101	0	0	25.10178117048346	135.02565645245392	MECOM;VEGFA
Obesity	4/1961	0.004664792952834903	0.013543886033581101	0	0	9.2156361778232	49.466879321329074	COL1A1;VIM;CD68;VEGFA
Trichohepatoenteric Syndrome	2/267	0.004714621672258848	0.013543886033581101	0	0	24.813836477987422	132.9298710222722	COL1A1;COL1A2
Adenocarcinoma of colon	2/267	0.004714621672258848	0.013543886033581101	0	0	24.813836477987422	132.9298710222722	CDH1;VEGFA
Hypothyroidism	2/268	0.004749116955718242	0.013543886033581101	0	0	24.719298245614034	132.2432172706769	COL1A2;VEGFA
Squamous cell carcinoma of the head and neck	3/934	0.004764293875269425	0.013543886033581101	0	0	12.284210526315789	65.67883300171178	CDH1;VIM;VEGFA
Myopia	2/269	0.004783730907806859	0.013543886033581101	0	0	24.625468164794007	131.56241355156135	COL1A1;VEGFA
recurrent muscle twitches (symptom)	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VIM
CATARACT, COPPOCK-LIKE	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VIM
Cataract, Pulverulent	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VIM
Eye Infections	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Dental Fluorosis, Acquired	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	COL1A2
Sickle Cell Dactylitis	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Melanoma, Experimental	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	CDH1
Hyaline Membrane Disease	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Idiopathic urticaria	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Urologic Neoplasms	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Acute mountain sickness	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Intracranial Arteriovenous Malformation	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Childhood Pre-B Acute Lymphoblastic Leukemia	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	MECOM
OROFACIAL CLEFT 1	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	CDH1
Complicated pneumoconiosis	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
Palmar-plantar erythrodysesthesia syndrome	1/12	0.00479070309341298	0.013543886033581101	0	0	259.4935064935065	1385.975083259077	VEGFA
ovarian neoplasm	3/938	0.004822122355979377	0.013609644821951946	0	0	12.229090909090909	65.23658837610444	MECOM;CDH1;VEGFA
Alzheimer's Disease	4/1982	0.0048504845782868415	0.013666568034767654	0	0	9.107178968655207	48.52921206313025	CDH1;VIM;CD68;VEGFA
Deafness	2/273	0.0049233718822437635	0.013848540134203368	0	0	24.257072570725708	128.89630175650373	COL1A1;COL1A2
Rectal Carcinoma	2/276	0.0050293449151893425	0.014073641185375234	0	0	23.987834549878347	126.95478770808306	VIM;VEGFA
Diabetes Mellitus, Insulin-Dependent	3/956	0.005087745859000164	0.014073641185375234	0	0	11.986778593913956	63.30122364629237	COL1A1;COL1A2;VEGFA
Infant, Premature	2/278	0.005100584040506339	0.014073641185375234	0	0	23.81159420289855	125.68712427110361	COL1A2;VEGFA
Epithelioid hemangioendothelioma	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Cerebral Amyloid Angiopathy, Hereditary	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	CD68
Cystadenoma, Mucinous	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Senile cardiac amyloidosis	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Neoplasms, Vascular Tissue	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Tendinosis	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Hydrosalpinx (disease)	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
TUBEROUS SCLEROSIS 1 (disorder)	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Liver and Intrahepatic Bile Duct Epithelial Neoplasm	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	COL1A1
Liver and Intrahepatic Bile Duct Neoplasm	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	COL1A1
Macular retinal edema	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Behavioral tic	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VIM
Blood urea nitrogen measurement	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	MECOM
cancer angiogenesis	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Cerebral metastasis	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
Opioid abuse	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	CD68
Peritoneal Neoplasms	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VIM
Perivascular Epithelioid Cell Neoplasms	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VIM
Curling Ulcer	1/13	0.005189022379499861	0.014073641185375234	0	0	237.85714285714286	1251.416370420653	VEGFA
cervical cancer	3/965	0.005223890220961889	0.014145209234682517	0	0	11.869022869022869	62.365933794582105	CDH1;VIM;VEGFA
Squamous cell carcinoma of lung	2/283	0.005280743970130371	0.014252881783458671	0	0	23.38196915776987	122.6077578172732	VIM;VEGFA
Cerebral Infarction	2/283	0.005280743970130371	0.014252881783458671	0	0	23.38196915776987	122.6077578172732	VIM;VEGFA
polyps	2/285	0.005353631201390715	0.014426263075799212	0	0	23.214369846878682	121.41069509746261	CDH1;VIM
Atrial Fibrillation	2/288	0.005463842228506863	0.014538928875778569	0	0	22.967365967365968	119.65085937730738	COL1A1;VEGFA
Congenital deafness	2/289	0.005500813649622556	0.014538928875778569	0	0	22.88617886178862	119.07356764888947	COL1A1;COL1A2
Fanconi Anemia	2/290	0.005537902151401884	0.014538928875778569	0	0	22.805555555555557	118.50084856550649	MECOM;CDH1
Extranodal marginal zone B-cell lymphoma	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Exudative retinopathy	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Familial Exudative Vitreoretinopathy	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Depressive Disorder, Treatment-Resistant	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Syringomyelia	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	COL1A1
Skin Diseases, Bacterial	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	COL1A1
Testicular Hydrocele	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	MECOM
Hyperextensibility of the finger joints	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	COL1A1
Vascular occlusion	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Viral Encephalitis	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Acute myocarditis	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Maxillary Sinus Squamous Cell Carcinoma	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Central retinal vein occlusion	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Myxoma of heart	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Nonspecific interstitial pneumonia	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	COL1A1
Coronary Occlusion	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Peritoneal Surface Malignancy	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VIM
POEMS Syndrome	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
Diastolic hypertension	1/14	0.0055872022837974	0.014538928875778569	0	0	219.54945054945054	1138.8637280375192	VEGFA
hearing impairment	2/294	0.005687425463822789	0.014753694671316347	0	0	22.488584474885844	116.25468347150861	COL1A1;COL1A2
Pituitary Adenoma	2/294	0.005687425463822789	0.014753694671316347	0	0	22.488584474885844	116.25468347150861	CDH1;VEGFA
Pituitary Neoplasms	2/296	0.0057628876493368035	0.014926236955114577	0	0	22.333333333333332	115.15773744215144	CDH1;VEGFA
Adenocarcinoma of large intestine	2/297	0.005800793610959772	0.01496223245062815	0	0	22.25649717514124	114.61563094041419	CDH1;VEGFA
Fibrosarcoma	2/298	0.005838816052389047	0.01496223245062815	0	0	22.18018018018018	114.07770674552971	COL1A1;VEGFA
Tumor Progression	4/2090	0.005887803783923792	0.01496223245062815	0	0	8.583892617449665	44.07719176528705	CDH1;VIM;CD68;VEGFA
Colon Carcinoma	4/2091	0.005898071574138731	0.01496223245062815	0	0	8.579300431241016	44.03866299278193	MECOM;CDH1;VIM;VEGFA
Senile Plaques	2/301	0.005953581502350017	0.01496223245062815	0	0	21.954292084726866	112.48857426818009	VIM;CD68
Esophageal Varices	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VEGFA
Salivary gland carcinoma	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	CDH1
Sclerosis of the skin	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	COL1A2
Foot-and-Mouth Disease	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VIM
Helicobacter Infections	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	CDH1
Stage 0 Breast Carcinoma	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VEGFA
Stromal keratitis	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VEGFA
Tic disorder	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VIM
Urinary Stress Incontinence	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	COL1A1
Uterine Corpus Carcinosarcoma	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VEGFA
Malignant tumor of peritoneum	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VEGFA
Maternal hypertension	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	COL1A1
Chronic ulcer	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VEGFA
Pancreatic Endocrine Carcinoma	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VEGFA
Congenital thrombocytopenia	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	MECOM
Patent ductus arteriosus - persisting type	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	VEGFA
Peg-shaped teeth	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	CDH1
Pointed tooth	1/15	0.0059852428364459065	0.01496223245062815	0	0	203.85714285714286	1043.434298452164	CDH1
Pancreatitis, Chronic	2/302	0.005992069110923024	0.01496223245062815	0	0	21.88	111.96692875742147	COL1A1;VEGFA
Malignant neoplasm of skin	2/307	0.006186247224316954	0.015424006532377696	0	0	21.51584699453552	109.41726149644045	COL1A1;VEGFA
Infection caused by Helicobacter pylori	2/308	0.006225430336829544	0.015430556971276167	0	0	21.444444444444443	108.91875030678122	CDH1;VEGFA
Fibroid Tumor	2/310	0.0063041434540528525	0.015430556971276167	0	0	21.303030303030305	107.93282921110205	COL1A1;VEGFA
Primary malignant neoplasm	3/1032	0.006308590001353973	0.015430556971276167	0	0	11.057142857142857	56.01375064973901	CDH1;VIM;VEGFA
Serous cystadenocarcinoma ovary	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Skin Manifestations	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Macular Edema, Cystoid	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Nephrosis, congenital	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Steroid-sensitive nephrotic syndrome	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Lateral Sclerosis	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VIM
Lepidic Predominant Adenocarcinoma	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Arachnoid Cysts	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	COL1A2
Mammary Analogue Secretory Carcinoma	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VIM
Benign neurologic neoplasms	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	MECOM
BREAST CANCER 3	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Cellulitis	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	COL1A1
Myxoma of the Endocardium	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Nephropathic cystinosis	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	COL1A2
Choroidal Neovascularization	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Dermatofibrosarcoma	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	COL1A1
Diverticulitis	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Empyema	1/16	0.006383144070851652	0.015430556971276167	0	0	190.25714285714287	961.5775796687342	VEGFA
Osteosarcoma of bone	3/1042	0.006481429672359587	0.015645477125174806	0	0	10.944947064485081	55.149554298255055	COL1A1;COL1A2;VEGFA
Agenesis of corpus callosum	2/317	0.006583273888665925	0.01586835382412538	0	0	20.822222222222223	104.59466778313461	VIM;VEGFA
Erythema Multiforme	1/17	0.00678090602009761	0.0162042281397175	0	0	178.35714285714286	890.6521752159383	VEGFA
Motor Neuron Disease, Lower	1/17	0.00678090602009761	0.0162042281397175	0	0	178.35714285714286	890.6521752159383	VIM
Adult Solid Neoplasm	1/17	0.00678090602009761	0.0162042281397175	0	0	178.35714285714286	890.6521752159383	VEGFA
Melnick-Needles Syndrome	1/17	0.00678090602009761	0.0162042281397175	0	0	178.35714285714286	890.6521752159383	VEGFA
Overlapping fingers	1/17	0.00678090602009761	0.0162042281397175	0	0	178.35714285714286	890.6521752159383	MECOM
Pathologic Neovascularization	1/17	0.00678090602009761	0.0162042281397175	0	0	178.35714285714286	890.6521752159383	VEGFA
Autoimmune Diseases	3/1060	0.006799830778557278	0.01622620563466887	0	0	10.748344370860927	53.64345568142902	COL1A1;VIM;VEGFA
Gastrointestinal Stromal Tumors	2/323	0.006827013896364823	0.016244592266956525	0	0	20.426791277258566	101.86570982365761	CDH1;VEGFA
Barrett Esophagus	2/323	0.006827013896364823	0.016244592266956525	0	0	20.426791277258566	101.86570982365761	VIM;VEGFA
T-Cell Lymphoma	2/324	0.006868038546673737	0.016318929196370076	0	0	20.36231884057971	101.42219994869825	CD68;VEGFA
Juvenile arthritis	2/326	0.0069504311638050814	0.016491207939156295	0	0	20.234567901234566	100.54458821169068	VIM;VEGFA
Osteopenia	2/329	0.007074877264081562	0.016653387907711016	0	0	20.045871559633028	99.25122317255348	COL1A1;COL1A2
Residual Cancer	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VIM
Retinal ischemia	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VEGFA
Smoldering myeloma	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VEGFA
Stenosis	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VEGFA
Immunosuppression	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VEGFA
Venous malformation	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VEGFA
Malignant neoplasm tonsil	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	CDH1
Benign neoplasm of stomach	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	CDH1
Carcinoma in situ of stomach	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	CDH1
Myoma	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VEGFA
Neoplasm of uncertain or unknown behavior of stomach	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	CDH1
Pleural Diseases	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VEGFA
Post-kala-azar dermal leishmaniasis	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	CD68
Proliferative Inflammatory Atrophy	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VIM
Pulpitis	1/18	0.007178528720410204	0.016653387907711016	0	0	167.85714285714286	828.6537822644398	VEGFA
Non-alcoholic Fatty Liver Disease	2/334	0.007284568292130397	0.016875916543435423	0	0	19.73895582329317	97.15508333747657	COL1A1;VEGFA
Arteriosclerosis	3/1087	0.007295175183906455	0.016877048830452105	0	0	10.465682656826568	51.49683194078477	VIM;CD68;VEGFA
Muscle Weakness	2/339	0.007497102373996547	0.017239820409434368	0	0	19.441147378832838	95.1301744004047	COL1A1;COL1A2
Aneurysm, Dissecting	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	COL1A1
Arteriovenous Malformations, Cerebral	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
Melanoma, Amelanotic	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
Spondyloepiphyseal Dysplasia Tarda, X-Linked	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
ABLEPHARON-MACROSTOMIA SYNDROME	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
Alcohol Withdrawal Delirium	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
Angiolymphoid hyperplasia	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
Lobular Neoplasia	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	CDH1
Cholecystitis	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
Dyschondroplasias	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
Pseudolymphoma	1/19	0.0075760122063041925	0.017239820409434368	0	0	158.52380952380952	774.0350338275504	VEGFA
Osteosarcoma	3/1103	0.007598863439878678	0.017266000733075167	0	0	10.304727272727273	50.28456081989774	COL1A1;COL1A2;VEGFA
Non-Small Cell Lung Carcinoma	4/2243	0.007608219747488158	0.017266000733075167	0	0	7.928986154533273	38.68176566686547	MECOM;CDH1;VIM;VEGFA
Cervix carcinoma	3/1105	0.007637359547936909	0.017308581149400495	0	0	10.284936479128856	50.13601425225509	CDH1;VIM;VEGFA
Multiple Sclerosis	3/1106	0.007656652327016248	0.017328759947711127	0	0	10.275067996373526	50.061985144970336	NFASC;CD68;VEGFA
Ankylosing spondylitis	2/348	0.007886798732909605	0.017685583332147613	0	0	18.926782273603084	91.65417271433054	CD68;VEGFA
Uterine Fibroids	2/349	0.007930662755911207	0.017685583332147613	0	0	18.87127761767531	91.2807221832765	COL1A1;VEGFA
Endophthalmitis	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	CD68
Adenocarcinoma of lung, stage I	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VEGFA
Filarial Elephantiases	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VEGFA
Gastric dysplasia	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VIM
Infantile neuronal ceroid lipofuscinosis	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VIM
Vulval intraepithelial neoplasia	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	CD68
Arteriosclerosis Obliterans	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VEGFA
Chronic myocardial ischemia	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VEGFA
Chronic small plaque psoriasis	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VEGFA
Congenital abnormality of vein	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VEGFA
Corneal pannus	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VEGFA
Cutaneous Fibrous Histiocytoma	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	COL1A1
Endometrial Endometrioid Adenocarcinoma	1/20	0.0079733565142536	0.017685583332147613	0	0	150.17293233082708	725.5830081396662	VEGFA
Retinal Diseases	2/355	0.008196209244616295	0.018155746374528527	0	0	18.544853635505195	89.09102570965904	VIM;VEGFA
Leukomalacia, Periventricular	1/21	0.008370561681605555	0.018347039270588787	0	0	142.65714285714284	682.3340060288631	VEGFA
Neoplasms, Neuroepithelial	1/21	0.008370561681605555	0.018347039270588787	0	0	142.65714285714284	682.3340060288631	CDH1
Van Buchem disease	1/21	0.008370561681605555	0.018347039270588787	0	0	142.65714285714284	682.3340060288631	VEGFA
Adult-Onset Still Disease	1/21	0.008370561681605555	0.018347039270588787	0	0	142.65714285714284	682.3340060288631	CD68
Lumbar disc disease	1/21	0.008370561681605555	0.018347039270588787	0	0	142.65714285714284	682.3340060288631	COL1A1
Nodular Goiter	1/21	0.008370561681605555	0.018347039270588787	0	0	142.65714285714284	682.3340060288631	VEGFA
Otitis Media with Effusion	1/21	0.008370561681605555	0.018347039270588787	0	0	142.65714285714284	682.3340060288631	VEGFA
Pancreatic Intraductal Papillary-Mucinous Neoplasm	1/21	0.008370561681605555	0.018347039270588787	0	0	142.65714285714284	682.3340060288631	VIM
Breast cancer, lobular	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	CDH1
Fragile skin	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	COL1A1
Gastrointestinal inflammation	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
Shwachman syndrome	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
Leukemia, T-Cell, Chronic	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
Squamous cell carcinoma of tonsil	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
Infantile muscular hypotonia	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	COL1A1
Adenoid cystic carcinoma of salivary gland	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
Intracranial Meningioma	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VIM
AIDS with Kaposi's sarcoma	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
CAMPOMELIC DYSPLASIA	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	COL1A1
Nephrosclerosis	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
Other specified manifestations of hyperkinetic syndrome	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
Diabetic Polyneuropathies	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	VEGFA
Disorder of Achilles tendon	1/22	0.008767627745742801	0.018845880257601793	0	0	135.85714285714286	643.5130349149837	COL1A1
Orbital separation excessive	2/368	0.008785392429798733	0.018859761355089173	0	0	17.87431693989071	84.62890081054442	COL1A1;CDH1
Retinal Vein Occlusion	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Granuloma	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Squamous Cell Neoplasms	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Stage III Colon Cancer AJCC v7	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Hypoxic-Ischemic Encephalopathy	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Aniridia	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Cholesteatoma	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Chronic glomerulonephritis	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Pena-Shokeir syndrome type I	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	COL1A2
Depletion of mitochondrial DNA	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VEGFA
Pseudoaphakia	1/23	0.009164554745730224	0.019399082888170067	0	0	129.67532467532467	608.4900471331728	VIM
Adenocarcinoma of lung (disorder)	3/1187	0.009319676935038814	0.019702434889283575	0	0	9.531081081081082	44.563783039491994	CDH1;VIM;VEGFA
Neoplasm Metastasis	5/3920	0.009504100424031058	0.01993539956666962	0	0	6.84418901660281	31.86676273256746	COL1A1;COL1A2;CDH1;VIM;VEGFA
Epilepsy, Benign Psychomotor, Childhood	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VEGFA
Healing ulcer	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VEGFA
Stage III Colon Cancer	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VEGFA
Uncinate Epilepsy	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VEGFA
X-linked centronuclear myopathy	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VIM
Lens dislocation	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	COL1A1
Bronchitis	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VEGFA
Carotid artery occlusion	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VEGFA
Childhood Solid Neoplasm	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VEGFA
Complications of Diabetes Mellitus	1/24	0.009561342717827156	0.01993539956666962	0	0	124.03105590062111	576.7477724354015	VEGFA
Hepatitis C, Chronic	2/386	0.009632181988361157	0.020058026912092897	0	0	17.020833333333332	79.02169522088865	CD68;VEGFA
Adenomatous Polyposis Coli	2/392	0.009922379863990194	0.02050608661505627	0	0	16.753846153846155	77.28486371702125	CDH1;VEGFA
Enterocolitis	1/25	0.009957991701556103	0.02050608661505627	0	0	118.85714285714286	547.8577209909951	VEGFA
Excessive wrinkled skin	1/25	0.009957991701556103	0.02050608661505627	0	0	118.85714285714286	547.8577209909951	COL1A2
Uterine Carcinosarcoma	1/25	0.009957991701556103	0.02050608661505627	0	0	118.85714285714286	547.8577209909951	VEGFA
Adolescent idiopathic scoliosis	1/25	0.009957991701556103	0.02050608661505627	0	0	118.85714285714286	547.8577209909951	COL1A2
Cancer of Digestive System	1/25	0.009957991701556103	0.02050608661505627	0	0	118.85714285714286	547.8577209909951	VEGFA
Non-infiltrating lobular carcinoma	1/25	0.009957991701556103	0.02050608661505627	0	0	118.85714285714286	547.8577209909951	CDH1
Port-Wine Stain	1/25	0.009957991701556103	0.02050608661505627	0	0	118.85714285714286	547.8577209909951	VEGFA
Diabetic foot ulcer	1/25	0.009957991701556103	0.02050608661505627	0	0	118.85714285714286	547.8577209909951	VEGFA
Lung diseases	2/393	0.00997112977584618	0.02050782301616699	0	0	16.71014492753623	77.00137355980357	VIM;VEGFA
Retrusion of lower jaw	2/395	0.010068957745723368	0.020607388367934455	0	0	16.623409669211195	76.43939274054206	COL1A1;COL1A2
Hypoplastic mandible condyle	2/395	0.010068957745723368	0.020607388367934455	0	0	16.623409669211195	76.43939274054206	COL1A1;COL1A2
Decreased projection of lower jaw	2/395	0.010068957745723368	0.020607388367934455	0	0	16.623409669211195	76.43939274054206	COL1A1;COL1A2
Decreased projection of mandible	2/395	0.010068957745723368	0.020607388367934455	0	0	16.623409669211195	76.43939274054206	COL1A1;COL1A2
Rhabdomyosarcoma	2/397	0.010167222763263586	0.020757561284117088	0	0	16.537552742616032	75.88398608993374	VIM;VEGFA
Aplasia/Hypoplasia of the mandible	2/397	0.010167222763263586	0.020757561284117088	0	0	16.537552742616032	75.88398608993374	COL1A1;COL1A2
Carcinoma, Transitional Cell	2/399	0.010265924252643159	0.020833906991647704	0	0	16.452560873215784	75.33504547732228	CDH1;VEGFA
Micrognathism	2/400	0.010315438493629567	0.020833906991647704	0	0	16.41038525963149	75.06296677596661	COL1A1;COL1A2
Recurrent Childhood Acute Lymphoblastic Leukemia	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	VEGFA
Epidermolysis Bullosa Simplex	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	VIM
Epilepsy, Lateral Temporal	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	VEGFA
Spondyloepiphyseal Dysplasia	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	VEGFA
Tuberculosis, Meningeal	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	VEGFA
Aortic root dilatation	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	COL1A1
MUTYH-Associate Polyposis	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	CD68
Carotid Artery Plaque	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	VEGFA
Pathological fracture	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	COL1A1
Dermatitis Herpetiformis	1/26	0.010354501736256563	0.020833906991647704	0	0	114.09714285714286	521.4620402892078	VEGFA
Neoplasms	3/1236	0.010423742515476456	0.020947954838330996	0	0	9.12846715328467	41.65930384832867	COL1A1;VIM;VEGFA
melanoma	4/2454	0.010510339867465154	0.02109656666538132	0	0	7.16	32.61663362071972	CDH1;VIM;CD68;VEGFA
Burkitt Lymphoma	2/407	0.010665083374958306	0.021246985701497547	0	0	16.120987654320988	73.20186008568021	VIM;VEGFA
Curvature of spine	2/408	0.010715466807776354	0.021246985701497547	0	0	16.080459770114942	72.94204427784635	COL1A1;COL1A2
Extramedullary Hematopoiesis (disorder)	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	VEGFA
Gastric lymphoma	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	CDH1
Vascular anomaly	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	VEGFA
Leg Ulcer	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	VEGFA
Lobular carcinoma in situ of breast	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	CDH1
Localized scleroderma	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	COL1A2
Mucinous neoplasm	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	VEGFA
Nevus elasticus	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	VEGFA
Congenital vascular anomaly	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	VEGFA
Corneal Diseases	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	VEGFA
Ectopia Lentis	1/27	0.010750872860949598	0.021246985701497547	0	0	109.7032967032967	497.25962914000377	COL1A1
AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	VEGFA
Esophageal atresia with or without tracheoesophageal fistula	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	VEGFA
GASTRIC CANCER, INTESTINAL	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	COL1A2
Hereditary non-polyposis colorectal cancer syndrome	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	CDH1
Tumor Expansion	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	VEGFA
Odontogenic Tumors	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	VIM
Philadelphia chromosome positive chronic myelogenous leukemia	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	MECOM
Placental Insufficiency	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	VEGFA
Rat Insulinoma	1/28	0.011147105113416074	0.021789600112186506	0	0	105.63492063492063	474.9953903533844	VEGFA
Carcinogenesis	5/4065	0.011156066244488776	0.021789600112186506	0	0	6.540229885057471	29.403381548554528	COL1A2;MECOM;CDH1;VIM;VEGFA
Metastatic melanoma	2/417	0.011173783725085186	0.021796099563098126	0	0	15.724497991967871	70.66880274581733	VIM;VEGFA
Diabetes	3/1268	0.011185528312956832	0.021796099563098126	0	0	8.882371541501977	39.90968958055649	COL1A1;CD68;VEGFA
Acquired scoliosis	2/418	0.011225247180096912	0.021847972341192123	0	0	15.685897435897436	70.42324552573054	COL1A1;COL1A2
Secondary malignant neoplasm of lymph node	3/1271	0.011258614200877003	0.021887375859047598	0	0	8.85993690851735	39.751185518578225	CDH1;VIM;VEGFA
Gall Bladder Diseases	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Head Neoplasms	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Stage IV Breast Cancer AJCC v6 and v7	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Hereditary hemorrhagic telangiectasia	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
High Grade Cervical Intraepithelial Neoplasia	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
T-Cell Prolymphocytic Leukemia	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Upper Aerodigestive Tract Neoplasms	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Intermittent Claudication	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Cardiac Lymphoma	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Chronic Kidney Insufficiency	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Paget Disease Extramammary	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	CDH1
Diffusely thickened skin	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	COL1A1
Primary peritoneal carcinoma	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	VEGFA
Dysgerminoma	1/29	0.011543198536568492	0.022080338485087437	0	0	101.85714285714286	454.4518266085444	CDH1
Carcinoma, Signet Ring Cell	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	CDH1
Femoral bowing	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	COL1A1
Stage II Colon Cancer AJCC v7	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
Optic Atrophy, Autosomal Dominant	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	CDH1
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
Tendinopathy	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	COL1A1
Acute Chest Syndrome	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
Welts	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	CD68
Adult Learning Disorders	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
Learning Disturbance	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
Arteriovenous fistula	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
Lymphadenitis	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	CD68
Cancer of Head	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
Cancer of Neck	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
Overlap syndrome	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	COL1A1
Developmental Academic Disorder	1/30	0.01193915316674268	0.022426247164557194	0	0	98.33990147783251	435.442406227662	VEGFA
nervous system disorder	2/436	0.012169921068432158	0.02283400263458362	0	0	15.021505376344086	66.22663050839631	CD68;VEGFA
Sebaceous Adenocarcinoma	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	CDH1
Hallux Valgus	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	COL1A1
Stage II Colon Cancer	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	VEGFA
Thick skin	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	COL1A1
Invasive Skin Melanoma	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	VEGFA
AIDS-Associated Nephropathy	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	VEGFA
Myelomonocytic leukemia	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	MECOM
Myxoma	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	VEGFA
Oral Ulcer	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	VEGFA
Pericardial effusion	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	VEGFA
Pulmonary Eosinophilia	1/31	0.012334969042911155	0.022860809292862008	0	0	95.05714285714286	417.8062796500496	CD68
Fibrillation	1/32	0.012730646209021314	0.023386253168114046	0	0	91.98617511520737	401.4040374155011	VEGFA
Gastrinoma	1/32	0.012730646209021314	0.023386253168114046	0	0	91.98617511520737	401.4040374155011	CDH1
Hallopeau-Siemens Disease	1/32	0.012730646209021314	0.023386253168114046	0	0	91.98617511520737	401.4040374155011	VEGFA
Verrucous carcinoma	1/32	0.012730646209021314	0.023386253168114046	0	0	91.98617511520737	401.4040374155011	CDH1
Bunion	1/32	0.012730646209021314	0.023386253168114046	0	0	91.98617511520737	401.4040374155011	COL1A1
Cervical high grade squamous intraepithelial lesion	1/32	0.012730646209021314	0.023386253168114046	0	0	91.98617511520737	401.4040374155011	VEGFA
Columnar Cell Change of the Breast	1/32	0.012730646209021314	0.023386253168114046	0	0	91.98617511520737	401.4040374155011	VEGFA
Peritoneal Fibrosis	1/32	0.012730646209021314	0.023386253168114046	0	0	91.98617511520737	401.4040374155011	VEGFA
Refractory anaemia with excess blasts	1/33	0.013126184702817524	0.023902266467576015	0	0	89.10714285714286	386.1142784895618	MECOM
Fibrous Dysplasia	1/33	0.013126184702817524	0.023902266467576015	0	0	89.10714285714286	386.1142784895618	COL1A1
High altitude pulmonary edema	1/33	0.013126184702817524	0.023902266467576015	0	0	89.10714285714286	386.1142784895618	VEGFA
Thrombotic Microangiopathies	1/33	0.013126184702817524	0.023902266467576015	0	0	89.10714285714286	386.1142784895618	VEGFA
Albuminuria	1/33	0.013126184702817524	0.023902266467576015	0	0	89.10714285714286	386.1142784895618	VEGFA
Ataxic	1/33	0.013126184702817524	0.023902266467576015	0	0	89.10714285714286	386.1142784895618	VEGFA
Mean blood pressure	1/33	0.013126184702817524	0.023902266467576015	0	0	89.10714285714286	386.1142784895618	MECOM
Polyarteritis Nodosa	1/33	0.013126184702817524	0.023902266467576015	0	0	89.10714285714286	386.1142784895618	VEGFA
Cholangiocarcinoma	2/455	0.013204441568385496	0.024018548021883326	0	0	14.37748344370861	62.214275450940896	CDH1;VEGFA
Renal interstitial fibrosis	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	VEGFA
Secondary malignant neoplasm of pancreas	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	VEGFA
Idiopathic osteoarthritis	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	COL1A1
Abnormality of the urinary system	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	VEGFA
Anastomosis	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	VEGFA
Cancer of Urinary Tract	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	VEGFA
Cholangitis	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	COL1A1
Cleft Lip with or without Cleft Palate	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	CDH1
prostatitis	1/34	0.013521584565055974	0.02435637478889132	0	0	86.40259740259741	371.8308142207318	VEGFA
Esophageal Atresia	1/35	0.013916845835577172	0.024906973019037257	0	0	83.85714285714286	358.4603752954014	VEGFA
Hepatitis B Virus-Related Hepatocellular Carcinoma	1/35	0.013916845835577172	0.024906973019037257	0	0	83.85714285714286	358.4603752954014	CDH1
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	1/35	0.013916845835577172	0.024906973019037257	0	0	83.85714285714286	358.4603752954014	NFASC
Varicose Ulcer	1/35	0.013916845835577172	0.024906973019037257	0	0	83.85714285714286	358.4603752954014	VEGFA
Limb defects	1/35	0.013916845835577172	0.024906973019037257	0	0	83.85714285714286	358.4603752954014	COL1A1
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	1/35	0.013916845835577172	0.024906973019037257	0	0	83.85714285714286	358.4603752954014	VEGFA
Malignant Head and Neck Neoplasm	2/470	0.014047961836014113	0.025114684182713332	0	0	13.905982905982906	59.31288238402851	VIM;VEGFA
Endometriosis of ovary	1/36	0.014311968554805366	0.025396131435548246	0	0	81.45714285714286	345.92071940977723	CDH1
Astrocytoma, low grade	1/36	0.014311968554805366	0.025396131435548246	0	0	81.45714285714286	345.92071940977723	VEGFA
Benign neoplasm of brain, unspecified	1/36	0.014311968554805366	0.025396131435548246	0	0	81.45714285714286	345.92071940977723	VEGFA
Familial medullary thyroid carcinoma	1/36	0.014311968554805366	0.025396131435548246	0	0	81.45714285714286	345.92071940977723	VEGFA
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	1/36	0.014311968554805366	0.025396131435548246	0	0	81.45714285714286	345.92071940977723	CD68
Learning Disorders	1/36	0.014311968554805366	0.025396131435548246	0	0	81.45714285714286	345.92071940977723	VEGFA
Peripheral arterial occlusive disease	1/36	0.014311968554805366	0.025396131435548246	0	0	81.45714285714286	345.92071940977723	VEGFA
Thyroid Neoplasm	2/476	0.014391930357941916	0.025510881867212665	0	0	13.725738396624472	58.21205920696073	CDH1;VEGFA
Sessile Serrated Adenoma/Polyp	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	VEGFA
Meningitis, Bacterial	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	VIM
Hemorrhage	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	VEGFA
Truncus Arteriosus, Persistent	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	VEGFA
ACTH-Secreting Pituitary Adenoma	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	CDH1
Multiple Epiphyseal Dysplasia	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	VEGFA
Cervical intraepithelial neoplasia grade 1	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	VIM
Ovarian Hyperstimulation Syndrome	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	VEGFA
Pseudoxanthoma Elasticum	1/37	0.014706952762456068	0.025822312850291285	0	0	79.19047619047619	334.1390605677817	VEGFA
Dermatitis, Atopic	2/484	0.014856348578011928	0.026057191827680227	0	0	13.492392807745505	56.793906716884116	CD68;VEGFA
Pain	2/485	0.014914864833288563	0.026132347207904753	0	0	13.46376811594203	56.62048901383082	COL1A1;VEGFA
Septic Shock	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	VEGFA
Growth abnormality	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	COL1A1
Idiopathic Membranous Glomerulonephritis	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	VEGFA
Lipoid nephrosis	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	VEGFA
Arteriovenous hemangioma	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	VEGFA
Bladder neck obstruction	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	COL1A1
Milroy Disease	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	VEGFA
Painful Bladder Syndrome	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	VEGFA
DOWN SYNDROME CRITICAL REGION	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	VEGFA
Radioulnar Synostosis	1/38	0.015101798500668919	0.02618482317995401	0	0	77.04633204633204	323.0507581480842	MECOM
Anemia	2/490	0.015208987825757244	0.026343293554894166	0	0	13.3224043715847	55.765835754927856	MECOM;VEGFA
Acute leukemia	2/492	0.01532735518775414	0.026520776403707372	0	0	13.266666666666667	55.42967394149399	MECOM;VEGFA
Recurrent Brain Neoplasm	1/39	0.015496505807542107	0.026620156217281393	0	0	75.01503759398496	312.59821718825697	VEGFA
Flat occiput	1/39	0.015496505807542107	0.026620156217281393	0	0	75.01503759398496	312.59821718825697	COL1A1
Stage 4S neuroblastoma	1/39	0.015496505807542107	0.026620156217281393	0	0	75.01503759398496	312.59821718825697	VEGFA
Stage IV Ovarian Carcinoma	1/39	0.015496505807542107	0.026620156217281393	0	0	75.01503759398496	312.59821718825697	VEGFA
Subependymal Giant Cell Astrocytoma	1/39	0.015496505807542107	0.026620156217281393	0	0	75.01503759398496	312.59821718825697	VEGFA
Primary malignant neoplasm of brain	1/39	0.015496505807542107	0.026620156217281393	0	0	75.01503759398496	312.59821718825697	VEGFA
Dislocations	1/39	0.015496505807542107	0.026620156217281393	0	0	75.01503759398496	312.59821718825697	COL1A1
Malignant Neoplasms	3/1438	0.015788283718151507	0.027019686691428624	0	0	7.759024390243902	32.18821298605467	CDH1;VIM;VEGFA
Rhizomelia	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	COL1A1
Degenerative Diseases, Spinal Cord	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	VIM
Dermatomyositis, Childhood Type	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	CD68
Neoplasm Recurrence, Local	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	VEGFA
Pneumonia, Bacterial	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	CD68
Hereditary Nonpolyposis Colorectal Neoplasms	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	CDH1
stage, ovarian epithelial cancer	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	VEGFA
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	MECOM
Chronic rejection of renal transplant	1/40	0.015891074726793453	0.027019686691428624	0	0	73.08791208791209	302.7299612299731	VEGFA
Malignant Glioma	2/504	0.016046140355647408	0.027255562233421463	0	0	12.941567065073041	53.478268496365146	VIM;VEGFA
Malignant neoplasm of thyroid	2/505	0.016106700871236147	0.027330597205719117	0	0	12.915175612988735	53.3205594062055	VIM;VEGFA
Rheumatic Heart Disease	1/41	0.01628550529596983	0.027410921123791804	0	0	71.25714285714285	293.399847205648	VIM
Schwartz-Jampel Syndrome	1/41	0.01628550529596983	0.027410921123791804	0	0	71.25714285714285	293.399847205648	VEGFA
Intestinal Polyps	1/41	0.01628550529596983	0.027410921123791804	0	0	71.25714285714285	293.399847205648	VEGFA
Laryngeal neoplasm	1/41	0.01628550529596983	0.027410921123791804	0	0	71.25714285714285	293.399847205648	CDH1
Arterial Occlusive Diseases	1/41	0.01628550529596983	0.027410921123791804	0	0	71.25714285714285	293.399847205648	VEGFA
Microcalcification	1/41	0.01628550529596983	0.027410921123791804	0	0	71.25714285714285	293.399847205648	COL1A1
Micronychia (disorder)	1/41	0.01628550529596983	0.027410921123791804	0	0	71.25714285714285	293.399847205648	CDH1
Monoclonal B-Cell Lymphocytosis	1/41	0.01628550529596983	0.027410921123791804	0	0	71.25714285714285	293.399847205648	VIM
Tumor Angiogenesis	2/511	0.01647219271940996	0.027697195016104646	0	0	12.759004584151931	52.389514078596825	CD68;VEGFA
Epiretinal Membrane	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	VEGFA
exudative macular degeneration	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	VEGFA
Degenerative Diseases, Central Nervous System	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	VIM
Memory Disorder, Semantic	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	VEGFA
Memory Disorder, Spatial	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	VEGFA
Mitral regurgitation, mild	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	COL1A2
Hernia	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	COL1A2
Vascular Neoplasms	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	VEGFA
Age-Related Memory Disorders	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	VEGFA
Diffuse Scleroderma	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	COL1A1
Ptosis	1/42	0.016679797556906864	0.027738686266122282	0	0	69.51567944250871	284.56639751252425	COL1A1
Malignant neoplasm of large intestine	2/516	0.01677954932063661	0.02787678114225285	0	0	12.631647211413748	51.63305086432523	CDH1;VEGFA
Macular dystrophy, corneal type 1	1/43	0.017073951550447674	0.028169486831005657	0	0	67.85714285714286	276.1922295799092	VEGFA
High Grade Lymphoma (neoplasm)	1/43	0.017073951550447674	0.028169486831005657	0	0	67.85714285714286	276.1922295799092	CDH1
Sarcoma, Epithelioid	1/43	0.017073951550447674	0.028169486831005657	0	0	67.85714285714286	276.1922295799092	VIM
Acute respiratory failure	1/43	0.017073951550447674	0.028169486831005657	0	0	67.85714285714286	276.1922295799092	VEGFA
intracranial glioma	1/43	0.017073951550447674	0.028169486831005657	0	0	67.85714285714286	276.1922295799092	CDH1
Dissection of aorta	1/43	0.017073951550447674	0.028169486831005657	0	0	67.85714285714286	276.1922295799092	COL1A1
Proliferative retinopathy	1/43	0.017073951550447674	0.028169486831005657	0	0	67.85714285714286	276.1922295799092	VEGFA
Hepatocarcinogenesis	2/527	0.017464585570000364	0.028425921450867482	0	0	12.36	50.028090408993805	CDH1;VEGFA
Endometriosis of uterus	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Arthritis, Adjuvant-Induced	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Arthritis, Collagen-Induced	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Arthritis, Experimental	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Split hand foot deformity 1	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	CD68
HELLP Syndrome	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Strawberry nevus of skin	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Thyroiditis	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Tumoral calcinosis	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	COL1A1
Memory Disorders	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Muscle damage	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	VEGFA
Neuromyelitis Optica	1/44	0.01746796731842876	0.028425921450867482	0	0	66.27574750830564	268.2435666902731	CD68
gallbladder neoplasm	1/45	0.017861844899874278	0.028897727733259257	0	0	64.76623376623377	260.68981695680077	CDH1
Leukemia, Plasma Cell	1/45	0.017861844899874278	0.028897727733259257	0	0	64.76623376623377	260.68981695680077	VEGFA
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	1/45	0.017861844899874278	0.028897727733259257	0	0	64.76623376623377	260.68981695680077	VEGFA
Ascites	1/45	0.017861844899874278	0.028897727733259257	0	0	64.76623376623377	260.68981695680077	VEGFA
Cerebral Amyloid Angiopathy	1/45	0.017861844899874278	0.028897727733259257	0	0	64.76623376623377	260.68981695680077	CD68
Endometrial Stromal Sarcoma	1/45	0.017861844899874278	0.028897727733259257	0	0	64.76623376623377	260.68981695680077	VIM
Diabetes Mellitus	3/1507	0.01793046838904276	0.028980640768336556	0	0	7.375531914893617	29.65888624503018	COL1A1;CD68;VEGFA
Sarcoidosis, Pulmonary	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Thrombasthenia	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Infiltrating Cervical Carcinoma	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Adult Diffuse Large B-Cell Lymphoma	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Malonic aciduria	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Moyamoya disease 1	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Childhood Diffuse Large B-Cell Lymphoma	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Obstructive nephropathy	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Cutaneous Mastocytosis	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Drusen	1/46	0.018255584335152574	0.02922295073995633	0	0	63.32380952380952	253.50320962011816	VEGFA
Metastatic Neoplasm	2/544	0.018547038139099317	0.029597375543062382	0	0	11.961869618696188	47.697299255914785	VIM;VEGFA
Carcinoma, Pancreatic Ductal	1/47	0.01864918566892	0.029597375543062382	0	0	61.94409937888199	246.6584798233955	VEGFA
Hemangioblastoma	1/47	0.01864918566892	0.029597375543062382	0	0	61.94409937888199	246.6584798233955	VEGFA
Mitral Valve Insufficiency	1/47	0.01864918566892	0.029597375543062382	0	0	61.94409937888199	246.6584798233955	COL1A2
Muscular Atrophy	1/47	0.01864918566892	0.029597375543062382	0	0	61.94409937888199	246.6584798233955	COL1A2
Colonic Polyps	1/47	0.01864918566892	0.029597375543062382	0	0	61.94409937888199	246.6584798233955	VEGFA
Diabetic Foot	1/47	0.01864918566892	0.029597375543062382	0	0	61.94409937888199	246.6584798233955	VEGFA
Disseminated neuroblastoma	1/47	0.01864918566892	0.029597375543062382	0	0	61.94409937888199	246.6584798233955	VEGFA
Protein measurement	1/47	0.01864918566892	0.029597375543062382	0	0	61.94409937888199	246.6584798233955	CD68
Fabry Disease	1/48	0.019042648937520508	0.0301072402159092	0	0	60.62310030395137	240.13259456270143	VEGFA
Synovial Cyst	1/48	0.019042648937520508	0.0301072402159092	0	0	60.62310030395137	240.13259456270143	VEGFA
Barrett Epithelium	1/48	0.019042648937520508	0.0301072402159092	0	0	60.62310030395137	240.13259456270143	VEGFA
Psychotic symptom	1/48	0.019042648937520508	0.0301072402159092	0	0	60.62310030395137	240.13259456270143	CD68
Thromboangiitis Obliterans	1/49	0.01943597418461227	0.030613035826188167	0	0	59.357142857142854	233.9045135601692	VEGFA
Abnormality of vision	1/49	0.01943597418461227	0.030613035826188167	0	0	59.357142857142854	233.9045135601692	CDH1
Intracranial Hemorrhages	1/49	0.01943597418461227	0.030613035826188167	0	0	59.357142857142854	233.9045135601692	VEGFA
Nervous System Neoplasms	1/49	0.01943597418461227	0.030613035826188167	0	0	59.357142857142854	233.9045135601692	VEGFA
Diabetic Nephropathy	2/561	0.01965804626823371	0.030882391503806506	0	0	11.587954680977937	45.532185830951974	COL1A2;VEGFA
Colorectal Carcinoma	4/2931	0.01967191578884028	0.030882391503806506	0	0	5.8302015715749915	22.904315662399345	MECOM;CDH1;VIM;VEGFA
Leishmaniasis, Cutaneous	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	COL1A1
stage, prostate cancer	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	VEGFA
Li-Fraumeni Syndrome	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	CDH1
Lymphedema	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	VEGFA
Moyamoya Disease	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	VEGFA
Calcinosis	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	COL1A1
Cervical Squamous Intraepithelial Neoplasia	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	VEGFA
Nephrosis	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	VIM
Opiate Addiction	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	CD68
Endocardial Cushion Defects	1/50	0.01982916145118511	0.030882391503806506	0	0	58.142857142857146	227.9549801512961	CD68
Steatohepatitis	2/569	0.020190659321592336	0.03134818547629358	0	0	11.419753086419753	44.56598829618415	COL1A1;VEGFA
Tumors of Adrenal Cortex	1/51	0.020222210774875234	0.03134818547629358	0	0	56.97714285714286	222.26633779925106	VEGFA
Angioimmunoblastic Lymphadenopathy	1/51	0.020222210774875234	0.03134818547629358	0	0	56.97714285714286	222.26633779925106	VEGFA
Bicuspid aortic valve	1/51	0.020222210774875234	0.03134818547629358	0	0	56.97714285714286	222.26633779925106	VEGFA
Cystadenoma	1/51	0.020222210774875234	0.03134818547629358	0	0	56.97714285714286	222.26633779925106	VEGFA
Malignant ascites	1/52	0.020615122198689464	0.0318094577496892	0	0	55.857142857142854	216.82236865801656	VEGFA
Behavioral Symptoms	1/52	0.020615122198689464	0.0318094577496892	0	0	55.857142857142854	216.82236865801656	COL1A1
Carcinomatosis of peritoneal cavity	1/52	0.020615122198689464	0.0318094577496892	0	0	55.857142857142854	216.82236865801656	VEGFA
Coronary Stenosis	1/52	0.020615122198689464	0.0318094577496892	0	0	55.857142857142854	216.82236865801656	VEGFA
Range of joint movement increased	1/52	0.020615122198689464	0.0318094577496892	0	0	55.857142857142854	216.82236865801656	COL1A1
Rous Sarcoma	1/53	0.02100789576309119	0.03223658705872687	0	0	54.78021978021978	211.60815123277547	COL1A2
granulosa cell tumor	1/53	0.02100789576309119	0.03223658705872687	0	0	54.78021978021978	211.60815123277547	VEGFA
Prostate cancer, familial	1/53	0.02100789576309119	0.03223658705872687	0	0	54.78021978021978	211.60815123277547	CDH1
Tumor-Associated Vasculature	1/53	0.02100789576309119	0.03223658705872687	0	0	54.78021978021978	211.60815123277547	VEGFA
Interstitial Cystitis	1/53	0.02100789576309119	0.03223658705872687	0	0	54.78021978021978	211.60815123277547	VIM
Nodular glomerulosclerosis	1/53	0.02100789576309119	0.03223658705872687	0	0	54.78021978021978	211.60815123277547	VEGFA
Cerebral Aneurysm	1/54	0.021400531511072123	0.03277877553762011	0	0	53.74393530997305	206.60993448840276	CD68
Pancreatic Diseases	1/54	0.021400531511072123	0.03277877553762011	0	0	53.74393530997305	206.60993448840276	VEGFA
Ganglioneuroma	1/55	0.02179302948367254	0.03322739778680603	0	0	52.74603174603175	201.8150262928954	VEGFA
Gingivitis	1/55	0.02179302948367254	0.03322739778680603	0	0	52.74603174603175	201.8150262928954	VEGFA
Hantavirus Infections	1/55	0.02179302948367254	0.03322739778680603	0	0	52.74603174603175	201.8150262928954	VEGFA
Atherogenesis	1/55	0.02179302948367254	0.03322739778680603	0	0	52.74603174603175	201.8150262928954	VEGFA
Early Rheumatoid Arthritis	1/55	0.02179302948367254	0.03322739778680603	0	0	52.74603174603175	201.8150262928954	VIM
Cystic Fibrosis	2/594	0.021894977129664775	0.03335234872354415	0	0	10.923423423423424	41.743841020012226	COL1A2;VEGFA
Adenoviral infections	1/56	0.022185389719098877	0.03370239531098081	0	0	51.784415584415584	197.21169430337935	VEGFA
Carotid Stenosis	1/56	0.022185389719098877	0.03370239531098081	0	0	51.784415584415584	197.21169430337935	VEGFA
Parathyroid Neoplasms	1/56	0.022185389719098877	0.03370239531098081	0	0	51.784415584415584	197.21169430337935	VEGFA
Sentinel node (disorder)	1/57	0.022577612257970867	0.03408095678397774	0	0	50.857142857142854	192.78907770536534	VEGFA
Geographic Atrophy	1/57	0.022577612257970867	0.03408095678397774	0	0	50.857142857142854	192.78907770536534	VEGFA
Heart Septal Defects	1/57	0.022577612257970867	0.03408095678397774	0	0	50.857142857142854	192.78907770536534	VEGFA
Ameloblastoma	1/57	0.022577612257970867	0.03408095678397774	0	0	50.857142857142854	192.78907770536534	VIM
Atrophic	1/57	0.022577612257970867	0.03408095678397774	0	0	50.857142857142854	192.78907770536534	VIM
Malignant neoplasm of colon stage IV	1/57	0.022577612257970867	0.03408095678397774	0	0	50.857142857142854	192.78907770536534	VEGFA
Cardiac defects	1/57	0.022577612257970867	0.03408095678397774	0	0	50.857142857142854	192.78907770536534	VEGFA
Liver and Intrahepatic Biliary Tract Carcinoma	2/607	0.022804861239364076	0.03439286487093968	0	0	10.681542699724519	40.38457960199227	CDH1;VEGFA
Colitis	2/608	0.0228755161771228	0.03442358925271158	0	0	10.663366336633663	40.28287214735202	VIM;VEGFA
Severe Dengue	1/58	0.0229696971452446	0.03442358925271158	0	0	49.962406015037594	188.53710846919242	VEGFA
Hepatosplenomegaly	1/58	0.0229696971452446	0.03442358925271158	0	0	49.962406015037594	188.53710846919242	MECOM
Carcinoma of Male Breast	1/58	0.0229696971452446	0.03442358925271158	0	0	49.962406015037594	188.53710846919242	VEGFA
Mycoplasma Infections	1/58	0.0229696971452446	0.03442358925271158	0	0	49.962406015037594	188.53710846919242	CDH1
Nerve Sheath Tumors	1/58	0.0229696971452446	0.03442358925271158	0	0	49.962406015037594	188.53710846919242	VEGFA
Oncocytic Neoplasm	1/58	0.0229696971452446	0.03442358925271158	0	0	49.962406015037594	188.53710846919242	CDH1
Fibromatosis, Aggressive	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	VEGFA
Sleep Apnea Syndromes	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	VEGFA
SVEINSSON CHORIORETINAL ATROPHY	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	VEGFA
Urinary Incontinence	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	COL1A1
Well Differentiated Pancreatic Endocrine Tumor	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	VEGFA
AICARDI-GOUTIERES SYNDROME 1	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	VEGFA
Anaplastic Oligodendroglioma	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	VEGFA
Leukocyte adhesion deficiency type 1	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	VIM
Chronic lung disease	1/59	0.023361644422266112	0.03473014518390363	0	0	49.09852216748769	184.44644096582132	VEGFA
Precursor Cell Lymphoblastic Leukemia Lymphoma	2/618	0.023587252317154427	0.03503431599734068	0	0	10.484848484848484	39.28723965616074	MECOM;VEGFA
AURAL ATRESIA, CONGENITAL	1/60	0.023753454121096102	0.03521845464354515	0	0	48.26392251815981	180.50838890404887	CD68
Bullous pemphigoid	1/60	0.023753454121096102	0.03521845464354515	0	0	48.26392251815981	180.50838890404887	VEGFA
Epithelial hyperplasia of skin	1/61	0.024145126293327844	0.03570396334864437	0	0	47.457142857142856	176.71486865577202	VIM
Viremia	1/61	0.024145126293327844	0.03570396334864437	0	0	47.457142857142856	176.71486865577202	VEGFA
Brain Infarction	1/61	0.024145126293327844	0.03570396334864437	0	0	47.457142857142856	176.71486865577202	VEGFA
Arthritis	2/630	0.024453716936620483	0.036090961642504076	0	0	10.278131634819532	38.14186952858724	VIM;VEGFA
Hereditary Malignant Neoplasm	1/62	0.024536660972781548	0.036090961642504076	0	0	46.676814988290396	173.05834842078664	CDH1
Macular degeneration	1/62	0.024536660972781548	0.036090961642504076	0	0	46.676814988290396	173.05834842078664	VEGFA
Bardet-Biedl Syndrome	1/62	0.024536660972781548	0.036090961642504076	0	0	46.676814988290396	173.05834842078664	VEGFA
Nijmegen Breakage Syndrome	1/62	0.024536660972781548	0.036090961642504076	0	0	46.676814988290396	173.05834842078664	VEGFA
Pemphigus Vulgaris	1/62	0.024536660972781548	0.036090961642504076	0	0	46.676814988290396	173.05834842078664	CDH1
Generalized hypotonia	2/633	0.02467243115249488	0.03625869177300569	0	0	10.227680929741151	37.863578531573395	COL1A1;COL1A2
Bulbo-Spinal Atrophy, X-Linked	1/63	0.02492805820599394	0.036409808307879064	0	0	45.92165898617512	169.5318022982446	VEGFA
Rheumatic Fever	1/63	0.02492805820599394	0.036409808307879064	0	0	45.92165898617512	169.5318022982446	VEGFA
Simple ear	1/63	0.02492805820599394	0.036409808307879064	0	0	45.92165898617512	169.5318022982446	COL1A1
gliosarcoma	1/63	0.02492805820599394	0.036409808307879064	0	0	45.92165898617512	169.5318022982446	VEGFA
Kidney Calculi	1/63	0.02492805820599394	0.036409808307879064	0	0	45.92165898617512	169.5318022982446	CDH1
Brain Edema	1/63	0.02492805820599394	0.036409808307879064	0	0	45.92165898617512	169.5318022982446	VEGFA
Necrotizing Enterocolitis	1/63	0.02492805820599394	0.036409808307879064	0	0	45.92165898617512	169.5318022982446	VEGFA
Esophageal Neoplasms	2/637	0.024965349736476624	0.03643237389365092	0	0	10.161154855643044	37.497368613734665	CDH1;VEGFA
Prostate carcinoma	4/3145	0.025103773755494066	0.03660235544070289	0	0	5.3648519579751675	19.768069020457595	MECOM;CDH1;VIM;VEGFA
Immunologic Deficiency Syndromes	2/641	0.02525974975613908	0.036724019547976924	0	0	10.095461658841941	37.13659051180602	CD68;VEGFA
Retinopathy of Prematurity	1/64	0.025319318033677134	0.036724019547976924	0	0	45.19047619047619	166.12866893112047	VEGFA
High-Grade Squamous Intraepithelial Lesions	1/64	0.025319318033677134	0.036724019547976924	0	0	45.19047619047619	166.12866893112047	VEGFA
Unspecified visual loss	1/64	0.025319318033677134	0.036724019547976924	0	0	45.19047619047619	166.12866893112047	VEGFA
Multiple Endocrine Neoplasia Type 2a	1/64	0.025319318033677134	0.036724019547976924	0	0	45.19047619047619	166.12866893112047	VEGFA
Osteopetrosis	1/64	0.025319318033677134	0.036724019547976924	0	0	45.19047619047619	166.12866893112047	VEGFA
Multiple, subcutaneous nodules	1/65	0.025710440490540786	0.03719428858475458	0	0	44.482142857142854	162.84281408743726	COL1A1
Subcutaneous nodule	1/65	0.025710440490540786	0.03719428858475458	0	0	44.482142857142854	162.84281408743726	COL1A1
Mammary Ductal Carcinoma	1/65	0.025710440490540786	0.03719428858475458	0	0	44.482142857142854	162.84281408743726	CDH1
Bronchitis, Chronic	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
Hypertrophic disorder of skin, unspecified	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
Giant Cell Tumor of Bone	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
Glycogen storage disease type II	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
GRN-related frontotemporal dementia	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
stage, non-small cell lung cancer	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
Thyroid Nodule	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
Cleft palate with cleft lip	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	CDH1
Congenital arteriovenous malformation	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
Proliferative vitreoretinopathy	1/66	0.026101425623281816	0.037435234685841846	0	0	43.79560439560439	159.66849674970803	VEGFA
Schistosomiasis	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	VEGFA
Gestational Diabetes	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	VEGFA
Tongue Carcinoma	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	VEGFA
Arteriopathic disease	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	VEGFA
Metastatic Renal Cell Cancer	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	VEGFA
Cerebral Hemorrhage	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	VEGFA
Cervical Adenocarcinoma	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	CDH1
neurofibroma	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	VEGFA
Oxyphilic Adenoma	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	CDH1
Pustulosis of Palms and Soles	1/67	0.026492273471440286	0.03767187736603785	0	0	43.12987012987013	156.6003384261292	VEGFA
Adenomatous polyp of colon	1/68	0.026882984076400464	0.03816239782079657	0	0	42.48400852878465	153.63329523076956	MECOM
Precocious Puberty	1/68	0.026882984076400464	0.03816239782079657	0	0	42.48400852878465	153.63329523076956	COL1A1
Pancreatic Neoplasm	2/665	0.02705702549216276	0.03832543712413652	0	0	9.717948717948717	35.07993471030808	CDH1;VEGFA
Histiocytosis, Langerhans-Cell	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	CD68
Simple Partial Status Epilepticus	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Grand Mal Status Epilepticus	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Status Epilepticus, Subclinical	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Adenomatous Polyps	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Non-Convulsive Status Epilepticus	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Chronic otitis media	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Complex Partial Status Epilepticus	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Diabetic Angiopathies	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Diphtheria	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Progressive supranuclear palsy	1/69	0.027273557473830964	0.03832543712413652	0	0	41.857142857142854	150.7626325151401	VEGFA
Angina, Unstable	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Brain Injuries, Focal	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Chromosome 8, trisomy	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	MECOM
Glaucoma, Open-Angle	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	CDH1
Injuries, Acute Brain	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Stromal Neoplasm	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Hereditary pancreatitis	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	CDH1
Benign Neoplasm	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Brain Injuries	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Brain Lacerations	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Neck Neoplasms	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Neurofibromatosis 2	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	VEGFA
Ovarian adenocarcinoma	1/70	0.02766399371512237	0.038426191606437454	0	0	41.24844720496895	147.9839017165653	CDH1
Malignant neoplasm of esophagus	2/673	0.0276677794480404	0.038426191606437454	0	0	9.598112270243417	34.43310049516046	CDH1;VEGFA
Rhabdoid Tumor	1/71	0.028054292838003377	0.03876931272062107	0	0	40.65714285714286	145.29291931699237	VIM
Leukemia, Myeloid, Chronic-Phase	1/71	0.028054292838003377	0.03876931272062107	0	0	40.65714285714286	145.29291931699237	MECOM
Neurofibromatoses	1/71	0.028054292838003377	0.03876931272062107	0	0	40.65714285714286	145.29291931699237	VEGFA
Pediatric Obesity	1/71	0.028054292838003377	0.03876931272062107	0	0	40.65714285714286	145.29291931699237	VEGFA
Duodenal Ulcer	1/71	0.028054292838003377	0.03876931272062107	0	0	40.65714285714286	145.29291931699237	VEGFA
Pterygium	1/71	0.028054292838003377	0.03876931272062107	0	0	40.65714285714286	145.29291931699237	VEGFA
Secondary malignant neoplasm of lung	2/683	0.028439340039344306	0.0391786546111883	0	0	9.452276064610867	33.64993151178535	VIM;VEGFA
Familial primary gastric lymphoma	1/72	0.02844445487658815	0.0391786546111883	0	0	40.08249496981891	142.68574756562285	CDH1
Neutrophil count decreased	1/72	0.02844445487658815	0.0391786546111883	0	0	40.08249496981891	142.68574756562285	MECOM
Contact hypersensitivity	1/72	0.02844445487658815	0.0391786546111883	0	0	40.08249496981891	142.68574756562285	VEGFA
Esophageal carcinoma	2/685	0.028594729410998842	0.039353142456721175	0	0	9.423621278672524	33.49657153734007	CDH1;VEGFA
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	1/73	0.028834479875414456	0.039487612834311424	0	0	39.523809523809526	140.15867684434946	CDH1
Syndactyly of fingers	1/73	0.028834479875414456	0.039487612834311424	0	0	39.523809523809526	140.15867684434946	CDH1
Urinary tract infection	1/73	0.028834479875414456	0.039487612834311424	0	0	39.523809523809526	140.15867684434946	VEGFA
Infertility	1/73	0.028834479875414456	0.039487612834311424	0	0	39.523809523809526	140.15867684434946	VEGFA
Attention Deficit Disorder	1/73	0.028834479875414456	0.039487612834311424	0	0	39.523809523809526	140.15867684434946	VEGFA
Bone neoplasms	1/73	0.028834479875414456	0.039487612834311424	0	0	39.523809523809526	140.15867684434946	VIM
Hamartoma	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	VEGFA
Hereditary gingival fibromatosis	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	VEGFA
Uveomeningoencephalitic Syndrome	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	VEGFA
Acoustic Neuroma	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	VEGFA
Keratitis	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	VEGFA
Marginal Zone B-Cell Lymphoma	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	CDH1
Necrotizing enterocolitis in fetus OR newborn	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	VEGFA
Chronic heart failure	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	VEGFA
DiGeorge Syndrome	1/74	0.02922436787889263	0.03972799154196651	0	0	38.980430528375734	137.70820955371116	VEGFA
Angiogenic Switch	1/75	0.029614118926114725	0.040061922440194124	0	0	38.45173745173745	135.33104533059262	VEGFA
Malignant Fibrous Histiocytoma	1/75	0.029614118926114725	0.040061922440194124	0	0	38.45173745173745	135.33104533059262	COL1A1
Mitral Valve Stenosis	1/75	0.029614118926114725	0.040061922440194124	0	0	38.45173745173745	135.33104533059262	VEGFA
Central Nervous System Neoplasms	1/75	0.029614118926114725	0.040061922440194124	0	0	38.45173745173745	135.33104533059262	VEGFA
Polycythemia	1/75	0.029614118926114725	0.040061922440194124	0	0	38.45173745173745	135.33104533059262	VEGFA
Proliferative diabetic retinopathy	1/75	0.029614118926114725	0.040061922440194124	0	0	38.45173745173745	135.33104533059262	VEGFA
Respiration Disorders	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	VEGFA
Stable angina	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	VEGFA
Systemic arterial pressure	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	MECOM
Acromegaly	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	VEGFA
Blood Pressure	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	MECOM
Blood pressure finding	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	MECOM
Chest Pain	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	VEGFA
Congenital pectus carinatum	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	COL1A1
Petit mal status	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	VEGFA
Early-Stage Breast Carcinoma	1/76	0.030003733059445183	0.04026245112080014	0	0	37.93714285714286	133.0240674608429	VEGFA
Rheumatoid Arthritis	3/1833	0.030277427061119563	0.040597064580343595	0	0	5.954754098360656	20.825876071563222	VIM;CD68;VEGFA
Neoplastic Syndromes, Hereditary	1/77	0.03039321031347104	0.040654270090512985	0	0	37.43609022556391	130.78433041717327	CDH1
Niemann-Pick Disease, Type C	1/77	0.03039321031347104	0.040654270090512985	0	0	37.43609022556391	130.78433041717327	VEGFA
Non-small cell lung cancer stage I	1/77	0.03039321031347104	0.040654270090512985	0	0	37.43609022556391	130.78433041717327	VEGFA
Giant Cell Glioblastoma	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Multiple Sclerosis, Relapsing-Remitting	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Pleural Effusion, Malignant	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Sudden infant death syndrome	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Marinesco-Sjogren syndrome	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Bronchial Hyperreactivity	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Peripheral Vascular Diseases	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Dyskinetic syndrome	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Pulmonary Edema	1/78	0.030782550739377516	0.040880011650701986	0	0	36.94805194805195	128.6090483496386	VEGFA
Spinocerebellar Ataxia Type 1	1/79	0.031171754372239124	0.04123274091427031	0	0	36.472527472527474	126.49558455333695	VEGFA
Polyendocrinopathies, Autoimmune	1/79	0.031171754372239124	0.04123274091427031	0	0	36.472527472527474	126.49558455333695	VIM
Lysosomal Storage Diseases	1/79	0.031171754372239124	0.04123274091427031	0	0	36.472527472527474	126.49558455333695	VEGFA
Malignancy	1/79	0.031171754372239124	0.04123274091427031	0	0	36.472527472527474	126.49558455333695	VIM
Chronic granulomatous disease	1/79	0.031171754372239124	0.04123274091427031	0	0	36.472527472527474	126.49558455333695	MECOM
Dementia, Vascular	1/80	0.0315608212516243	0.04161537537368327	0	0	36.00904159132007	124.44144169317283	VEGFA
Luminal B Breast Carcinoma	1/80	0.0315608212516243	0.04161537537368327	0	0	36.00904159132007	124.44144169317283	CDH1
Paroxysmal kinesigenic choreoathetosis	1/80	0.0315608212516243	0.04161537537368327	0	0	36.00904159132007	124.44144169317283	VEGFA
Desmoplastic	1/80	0.0315608212516243	0.04161537537368327	0	0	36.00904159132007	124.44144169317283	COL1A2
Sensory neuropathy	1/81	0.03194975141989611	0.042061709051607506	0	0	35.55714285714286	122.44425280744703	VEGFA
Peptic Ulcer	1/81	0.03194975141989611	0.042061709051607506	0	0	35.55714285714286	122.44425280744703	VEGFA
Salivary Gland Neoplasms	1/82	0.032338544922317344	0.042506456209949035	0	0	35.116402116402114	120.50177299317811	CDH1
Malignant neoplasm of tongue	1/82	0.032338544922317344	0.042506456209949035	0	0	35.116402116402114	120.50177299317811	VEGFA
Lymphoma, Large-Cell, Follicular	1/83	0.032727201789121446	0.04284848711479951	0	0	34.68641114982579	118.611871734907	VEGFA
Hay fever	1/83	0.032727201789121446	0.04284848711479951	0	0	34.68641114982579	118.611871734907	VEGFA
Testicular Neoplasms	1/83	0.032727201789121446	0.04284848711479951	0	0	34.68641114982579	118.611871734907	VEGFA
bone destruction	1/83	0.032727201789121446	0.04284848711479951	0	0	34.68641114982579	118.611871734907	VEGFA
Paraganglioma	1/83	0.032727201789121446	0.04284848711479951	0	0	34.68641114982579	118.611871734907	VEGFA
Skin Ulcer	1/84	0.03311572207601827	0.04328920409310225	0	0	34.26678141135972	116.772525740896	COL1A1
Hemochromatosis	1/84	0.03311572207601827	0.04328920409310225	0	0	34.26678141135972	116.772525740896	CD68
Neurodegenerative Disorders	2/745	0.033420525395896274	0.043557948948959556	0	0	8.635711081202333	29.349198446606792	VIM;VEGFA
Alzheimer's Disease, Focal Onset	1/85	0.03350410581625606	0.043557948948959556	0	0	33.857142857142854	114.98181239681574	VEGFA
Hip Dislocation, Congenital	1/85	0.03350410581625606	0.043557948948959556	0	0	33.857142857142854	114.98181239681574	COL1A1
Acute Confusional Senile Dementia	1/85	0.03350410581625606	0.043557948948959556	0	0	33.857142857142854	114.98181239681574	VEGFA
Lesion of brain	1/85	0.03350410581625606	0.043557948948959556	0	0	33.857142857142854	114.98181239681574	VEGFA
Demyelinating Diseases	1/85	0.03350410581625606	0.043557948948959556	0	0	33.857142857142854	114.98181239681574	NFASC
Prostatic Hyperplasia	1/85	0.03350410581625606	0.043557948948959556	0	0	33.857142857142854	114.98181239681574	VEGFA
Short stature	2/750	0.03383678240091692	0.04375576229097651	0	0	8.575757575757576	29.039288888146526	COL1A1;COL1A2
Recurrent urinary tract infection	1/86	0.03389235304552857	0.04375576229097651	0	0	33.457142857142856	113.23790361856584	VEGFA
Cystadenocarcinoma, Serous	1/86	0.03389235304552857	0.04375576229097651	0	0	33.457142857142856	113.23790361856584	VEGFA
Malaria, Cerebral	1/86	0.03389235304552857	0.04375576229097651	0	0	33.457142857142856	113.23790361856584	VEGFA
Headache	1/86	0.03389235304552857	0.04375576229097651	0	0	33.457142857142856	113.23790361856584	VEGFA
Herpes NOS	1/86	0.03389235304552857	0.04375576229097651	0	0	33.457142857142856	113.23790361856584	VEGFA
Myocardial Reperfusion Injury	1/86	0.03389235304552857	0.04375576229097651	0	0	33.457142857142856	113.23790361856584	VEGFA
Curvature of digit	1/86	0.03389235304552857	0.04375576229097651	0	0	33.457142857142856	113.23790361856584	CDH1
Diabetic Neuropathies	1/86	0.03389235304552857	0.04375576229097651	0	0	33.457142857142856	113.23790361856584	VEGFA
Gynecomastia	1/87	0.03428046381322864	0.04408620943752149	0	0	33.06644518272425	111.53906016025832	VEGFA
Hemangiosarcoma	1/87	0.03428046381322864	0.04408620943752149	0	0	33.06644518272425	111.53906016025832	VEGFA
Actinic keratosis	1/87	0.03428046381322864	0.04408620943752149	0	0	33.06644518272425	111.53906016025832	VIM
Malignant Childhood Neoplasm	1/87	0.03428046381322864	0.04408620943752149	0	0	33.06644518272425	111.53906016025832	VEGFA
Contact Dermatitis	1/87	0.03428046381322864	0.04408620943752149	0	0	33.06644518272425	111.53906016025832	VEGFA
Schizophrenia	3/1923	0.03434732587822774	0.04413816607464088	0	0	5.6475	19.039027708381397	NFASC;VIM;VEGFA
Brain Tumor, Primary	1/88	0.03466843816114944	0.044389140192197495	0	0	32.68472906403941	109.88362635662662	VEGFA
Retroviridae Infections	1/88	0.03466843816114944	0.044389140192197495	0	0	32.68472906403941	109.88362635662662	VEGFA
Abnormality of the skeletal system	1/88	0.03466843816114944	0.044389140192197495	0	0	32.68472906403941	109.88362635662662	COL1A2
Iron Overload	1/88	0.03466843816114944	0.044389140192197495	0	0	32.68472906403941	109.88362635662662	VEGFA
Coronary Arteriosclerosis	2/760	0.034675689250859315	0.044389140192197495	0	0	8.458223394898857	28.43414860193722	CD68;VEGFA
Acute Kidney Insufficiency	1/89	0.035056276120956284	0.044738996610371146	0	0	32.311688311688314	108.27002521488092	VEGFA
Bronchioloalveolar Adenocarcinoma	1/89	0.035056276120956284	0.044738996610371146	0	0	32.311688311688314	108.27002521488092	VEGFA
Congenital clinodactyly	1/89	0.035056276120956284	0.044738996610371146	0	0	32.311688311688314	108.27002521488092	CDH1
Creutzfeldt-Jakob disease	1/89	0.035056276120956284	0.044738996610371146	0	0	32.311688311688314	108.27002521488092	CD68
Cerebrovascular accident	2/768	0.03535291735634835	0.04502707910741812	0	0	8.366405570060923	27.963659481840583	CD68;VEGFA
Skin carcinoma	1/90	0.03544397773863309	0.04502707910741812	0	0	31.947030497592294	106.6967538219128	COL1A1
Adenovirus Infections	1/90	0.03544397773863309	0.04502707910741812	0	0	31.947030497592294	106.6967538219128	VIM
Bacteremia	1/90	0.03544397773863309	0.04502707910741812	0	0	31.947030497592294	106.6967538219128	VIM
Motor neuron atrophy	1/90	0.03544397773863309	0.04502707910741812	0	0	31.947030497592294	106.6967538219128	VEGFA
Degenerative disorder	1/90	0.03544397773863309	0.04502707910741812	0	0	31.947030497592294	106.6967538219128	VEGFA
Thyroid associated opthalmopathies	1/92	0.036218972118804385	0.045941631554498645	0	0	31.24175824175824	103.66553385683846	CD68
Acute kidney injury	1/92	0.036218972118804385	0.045941631554498645	0	0	31.24175824175824	103.66553385683846	VEGFA
Intraepithelial Neoplasia	1/93	0.03660626495698383	0.04632720026422536	0	0	30.900621118012424	102.2049130477516	VEGFA
Mucinous Adenocarcinoma	1/93	0.03660626495698383	0.04632720026422536	0	0	30.900621118012424	102.2049130477516	VEGFA
Edema	1/93	0.03660626495698383	0.04632720026422536	0	0	30.900621118012424	102.2049130477516	VEGFA
Traditional Serrated Adenoma	1/94	0.03699342162417383	0.04671084577526264	0	0	30.566820276497698	100.7792703363177	VIM
airway disease	1/94	0.03699342162417383	0.04671084577526264	0	0	30.566820276497698	100.7792703363177	VEGFA
Myelodysplasia	1/94	0.03699342162417383	0.04671084577526264	0	0	30.566820276497698	100.7792703363177	MECOM
Rheumatism	1/95	0.037380442146754005	0.046950736069868736	0	0	30.24012158054711	99.3874148810262	VEGFA
Rotting teeth	1/95	0.037380442146754005	0.046950736069868736	0	0	30.24012158054711	99.3874148810262	CDH1
Gastric ulcer	1/95	0.037380442146754005	0.046950736069868736	0	0	30.24012158054711	99.3874148810262	VEGFA
Agenesis	1/95	0.037380442146754005	0.046950736069868736	0	0	30.24012158054711	99.3874148810262	COL1A2
Limb ischemia	1/95	0.037380442146754005	0.046950736069868736	0	0	30.24012158054711	99.3874148810262	VEGFA
Membranous glomerulonephritis	1/95	0.037380442146754005	0.046950736069868736	0	0	30.24012158054711	99.3874148810262	VEGFA
Polyneuropathy	1/95	0.037380442146754005	0.046950736069868736	0	0	30.24012158054711	99.3874148810262	VEGFA
Retinal Detachment	1/96	0.03776732657425956	0.04725874022945607	0	0	29.9203007518797	98.02820827717792	VEGFA
Idiopathic pulmonary hypertension	1/96	0.03776732657425956	0.04725874022945607	0	0	29.9203007518797	98.02820827717792	VEGFA
IMMUNE SUPPRESSION	1/96	0.03776732657425956	0.04725874022945607	0	0	29.9203007518797	98.02820827717792	VEGFA
Broad forehead	1/96	0.03776732657425956	0.04725874022945607	0	0	29.9203007518797	98.02820827717792	COL1A1
Cardiac fibrosis	1/96	0.03776732657425956	0.04725874022945607	0	0	29.9203007518797	98.02820827717792	VEGFA
Neoplasms, Intracranial	1/97	0.03815407494862228	0.04759984817823633	0	0	29.607142857142858	96.7005617556944	VEGFA
Hemoglobin measurement	1/97	0.03815407494862228	0.04759984817823633	0	0	29.607142857142858	96.7005617556944	VEGFA
Adult Hepatocellular Carcinoma	1/97	0.03815407494862228	0.04759984817823633	0	0	29.607142857142858	96.7005617556944	CDH1
Ductal Breast Carcinoma	1/97	0.03815407494862228	0.04759984817823633	0	0	29.607142857142858	96.7005617556944	VEGFA
Frontotemporal Lobar Degeneration	1/98	0.03854068730993136	0.04788477809901984	0	0	29.30044182621502	95.40343353076332	VEGFA
Henoch-Schoenlein Purpura	1/98	0.03854068730993136	0.04788477809901984	0	0	29.30044182621502	95.40343353076332	VEGFA
Hypercalcemia	1/98	0.03854068730993136	0.04788477809901984	0	0	29.30044182621502	95.40343353076332	VIM
Myelofibrosis	1/98	0.03854068730993136	0.04788477809901984	0	0	29.30044182621502	95.40343353076332	VEGFA
Central Serous Chorioretinopathy	1/98	0.03854068730993136	0.04788477809901984	0	0	29.30044182621502	95.40343353076332	VIM
Malignant neoplasm of liver	2/805	0.038554710423851106	0.04788477809901984	0	0	7.965545869655458	25.933244452038192	CDH1;VEGFA
Nephrolithiasis	1/99	0.038927163698028566	0.04831139066094617	0	0	29.0	94.13582631773187	CDH1
Childhood Neuroblastoma	1/100	0.03931350415205654	0.048646086740081834	0	0	28.705627705627705	92.89678500716381	VEGFA
Oral Cavity Carcinoma	1/100	0.03931350415205654	0.048646086740081834	0	0	28.705627705627705	92.89678500716381	VEGFA
Polymyositis	1/100	0.03931350415205654	0.048646086740081834	0	0	28.705627705627705	92.89678500716381	VEGFA
Rash and Dermatitis Adverse Event Associated with Chemoradiation	1/100	0.03931350415205654	0.048646086740081834	0	0	28.705627705627705	92.89678500716381	VEGFA
Forced expiratory volume function	1/101	0.039699708710484755	0.04898695569572425	0	0	28.417142857142856	91.68539448196991	MECOM
Hemangioma	1/101	0.039699708710484755	0.04898695569572425	0	0	28.417142857142856	91.68539448196991	VEGFA
Otitis Media	1/101	0.039699708710484755	0.04898695569572425	0	0	28.417142857142856	91.68539448196991	MECOM
Psoriasis	2/818	0.03970645329773333	0.04898695569572425	0	0	7.833333333333333	25.272225497864593	CD68;VEGFA
Heart Decompensation	1/102	0.04008577742562173	0.049381888290943164	0	0	28.134370579915135	90.5007775576607	VEGFA
Inflammatory Breast Carcinoma	1/102	0.04008577742562173	0.049381888290943164	0	0	28.134370579915135	90.5007775576607	VEGFA
Enterovirus Infections	1/104	0.04085750745521912	0.05025834987854387	0	0	27.58529819694868	88.20853410483198	VIM
Ischemia	1/104	0.04085750745521912	0.05025834987854387	0	0	27.58529819694868	88.20853410483198	CD68
Amyloidosis	2/833	0.04105241822325157	0.05046089432305352	0	0	7.6859205776173285	24.540418358489895	CD68;VEGFA
M5b Acute differentiated monocytic leukemia	1/105	0.0412431688635261	0.050620754719912835	0	0	27.318681318681318	87.09932616586799	VEGFA
Mixed Salivary Gland Tumor	1/105	0.0412431688635261	0.050620754719912835	0	0	27.318681318681318	87.09932616586799	VEGFA
Hepatitis B	2/839	0.041595870045193585	0.05094399307151761	0	0	7.628434886499402	24.256549352764022	CDH1;VIM
Heart Failure, Right-Sided	1/106	0.041628694578224525	0.05094399307151761	0	0	27.057142857142857	86.01372572734715	VEGFA
Atrial Premature Complexes	1/106	0.041628694578224525	0.05094399307151761	0	0	27.057142857142857	86.01372572734715	CDH1
Chronic graft-versus-host disease	1/106	0.041628694578224525	0.05094399307151761	0	0	27.057142857142857	86.01372572734715	VEGFA
Dermatitis, Allergic Contact	1/107	0.04201408464648069	0.051302703653242895	0	0	26.80053908355795	84.9510186277944	VEGFA
Basal cell carcinoma	1/107	0.04201408464648069	0.051302703653242895	0	0	26.80053908355795	84.9510186277944	VEGFA
Pleural effusion disorder	1/107	0.04201408464648069	0.051302703653242895	0	0	26.80053908355795	84.9510186277944	VEGFA
Carcinoma, Lewis Lung	1/108	0.04239933910860823	0.051621969075298195	0	0	26.548731642189587	83.91051867901874	VEGFA
Leukemia, Myelomonocytic, Chronic	1/108	0.04239933910860823	0.051621969075298195	0	0	26.548731642189587	83.91051867901874	CD68
Vesico-Ureteral Reflux	1/108	0.04239933910860823	0.051621969075298195	0	0	26.548731642189587	83.91051867901874	VEGFA
Myocardial Failure	1/108	0.04239933910860823	0.051621969075298195	0	0	26.548731642189587	83.91051867901874	VEGFA
Glioblastoma Multiforme	2/854	0.042967049865381586	0.05227501033950145	0	0	7.488262910798122	23.567972648249196	VIM;VEGFA
Reperfusion Injury	1/110	0.04316944138193159	0.0523684568909541	0	0	26.05897771952818	81.8935273489654	VIM
Weight Gain	1/110	0.04316944138193159	0.0523684568909541	0	0	26.05897771952818	81.8935273489654	VIM
Luminal A Breast Carcinoma	1/110	0.04316944138193159	0.0523684568909541	0	0	26.05897771952818	81.8935273489654	VIM
Borderline Personality Disorder	1/110	0.04316944138193159	0.0523684568909541	0	0	26.05897771952818	81.8935273489654	VEGFA
Umbilical hernia	1/111	0.043554289278712535	0.052720286296728966	0	0	25.820779220779222	80.91579173517657	COL1A1
Multiple Endocrine Neoplasia Type 1	1/111	0.043554289278712535	0.052720286296728966	0	0	25.820779220779222	80.91579173517657	VEGFA
Congenital cataract	1/111	0.043554289278712535	0.052720286296728966	0	0	25.820779220779222	80.91579173517657	VIM
Glomerulosclerosis (disorder)	1/112	0.04393900172534527	0.05303202234289139	0	0	25.586872586872587	79.95777249377652	VEGFA
Synovitis	1/112	0.04393900172534527	0.05303202234289139	0	0	25.586872586872587	79.95777249377652	VEGFA
Bilateral cataracts (disorder)	1/112	0.04393900172534527	0.05303202234289139	0	0	25.586872586872587	79.95777249377652	VIM
Cholera	1/112	0.04393900172534527	0.05303202234289139	0	0	25.586872586872587	79.95777249377652	VEGFA
Adenocarcinoma, Clear Cell	1/113	0.044323578770219654	0.053380310027961286	0	0	25.357142857142858	79.01890460278796	VEGFA
Erythema	1/113	0.044323578770219654	0.053380310027961286	0	0	25.357142857142858	79.01890460278796	COL1A1
Lipodystrophy	1/113	0.044323578770219654	0.053380310027961286	0	0	25.357142857142858	79.01890460278796	CD68
Carcinoma, Endometrioid	1/114	0.04470802045537426	0.05368824918615138	0	0	25.131479140328697	78.09864401057703	CDH1
Gingival Diseases	1/114	0.04470802045537426	0.05368824918615138	0	0	25.131479140328697	78.09864401057703	VEGFA
Neuroectodermal Tumor, Primitive	1/114	0.04470802045537426	0.05368824918615138	0	0	25.131479140328697	78.09864401057703	COL1A2
Dermatomyositis	1/114	0.04470802045537426	0.05368824918615138	0	0	25.131479140328697	78.09864401057703	VEGFA
Carcinoma, Cribriform	1/115	0.04509232682471626	0.05407189154825789	0	0	24.909774436090224	77.19646667797144	VEGFA
Carcinoma, Granular Cell	1/115	0.04509232682471626	0.05407189154825789	0	0	24.909774436090224	77.19646667797144	VEGFA
Alzheimer Disease, Early Onset	1/116	0.0454764979116999	0.05429835255312486	0	0	24.69192546583851	76.31186768318003	VEGFA
Experimental Hepatoma	1/116	0.0454764979116999	0.05429835255312486	0	0	24.69192546583851	76.31186768318003	CDH1
Familial (FPAH)	1/116	0.0454764979116999	0.05429835255312486	0	0	24.69192546583851	76.31186768318003	CDH1
Liver Neoplasms, Experimental	1/116	0.0454764979116999	0.05429835255312486	0	0	24.69192546583851	76.31186768318003	CDH1
Ischemic cardiomyopathy	1/116	0.0454764979116999	0.05429835255312486	0	0	24.69192546583851	76.31186768318003	VEGFA
Pancytopenia	1/116	0.0454764979116999	0.05429835255312486	0	0	24.69192546583851	76.31186768318003	MECOM
Adenocarcinoma, Basal Cell	1/117	0.045860533758481335	0.05463955022081919	0	0	24.47783251231527	75.44436035722065	VEGFA
Hyperhomocysteinemia	1/117	0.045860533758481335	0.05463955022081919	0	0	24.47783251231527	75.44436035722065	VEGFA
Diastolic blood pressure	1/117	0.045860533758481335	0.05463955022081919	0	0	24.47783251231527	75.44436035722065	MECOM
Erectile dysfunction	1/118	0.04624443440431755	0.05501834278630647	0	0	24.267399267399266	74.59347548161342	VEGFA
Systolic Pressure	1/118	0.04624443440431755	0.05501834278630647	0	0	24.267399267399266	74.59347548161342	MECOM
Hepatoma, Novikoff	1/119	0.04662819989389979	0.05535646791674367	0	0	24.06053268765133	73.75876051746786	CDH1
Giant Cell Arteritis	1/119	0.04662819989389979	0.05535646791674367	0	0	24.06053268765133	73.75876051746786	VEGFA
Von Hippel-Lindau Syndrome	1/119	0.04662819989389979	0.05535646791674367	0	0	24.06053268765133	73.75876051746786	VEGFA
Hepatoma, Morris	1/121	0.047395325572656036	0.056187208994449366	0	0	23.65714285714286	72.13610926322491	CDH1
Juvenile Myelomonocytic Leukemia	1/121	0.047395325572656036	0.056187208994449366	0	0	23.65714285714286	72.13610926322491	MECOM
Adenocarcinoma, Oxyphilic	1/122	0.047778685835917385	0.05652116877610652	0	0	23.460448642266822	71.34734495992407	VEGFA
Acute Megakaryocytic Leukemias	1/122	0.047778685835917385	0.05652116877610652	0	0	23.460448642266822	71.34734495992407	MECOM
Congenital heart disease	1/122	0.047778685835917385	0.05652116877610652	0	0	23.460448642266822	71.34734495992407	VEGFA
Acute lymphocytic leukemia	2/907	0.04795281215976959	0.05668695299964258	0	0	7.030202578268876	21.354506295438032	MECOM;VEGFA
Peripheral T-Cell Lymphoma	1/123	0.048161911106035224	0.056893815669169095	0	0	23.26697892271663	70.5730932589798	CD68
Inflammatory Bowel Diseases	2/911	0.048337848906481816	0.05706123989809743	0	0	6.997799779977997	21.200117172141383	CD68;VEGFA
Coronary heart disease	2/913	0.04853082098965028	0.05718436608005307	0	0	6.981705085986096	21.123541099357983	MECOM;VEGFA
Hyperthyroidism	1/124	0.048545001420476706	0.05718436608005307	0	0	23.076655052264808	69.81297485230687	VIM
CNS disorder	1/124	0.048545001420476706	0.05718436608005307	0	0	23.076655052264808	69.81297485230687	VIM
Adenocarcinoma, Tubular	1/125	0.0489279568229514	0.057513623665033785	0	0	22.889400921658986	69.0666232697606	VEGFA
Tetralogy of Fallot	1/125	0.0489279568229514	0.057513623665033785	0	0	22.889400921658986	69.0666232697606	VEGFA
Peripheral Arterial Diseases	1/125	0.0489279568229514	0.057513623665033785	0	0	22.889400921658986	69.0666232697606	VEGFA
Left-Sided Heart Failure	1/126	0.04931077734976695	0.05788203843730561	0	0	22.705142857142857	68.33368435289212	VEGFA
Memory Loss	1/126	0.04931077734976695	0.05788203843730561	0	0	22.705142857142857	68.33368435289212	VEGFA
Renal glomerular disease	1/127	0.049693463055301444	0.0582902224868093	0	0	22.523809523809526	67.61381573648762	VEGFA
Sarcomatoid Renal Cell Carcinoma	1/128	0.05007601395994044	0.0586564545541999	0	0	22.34533183352081	66.90668639044372	VIM
Hereditary Nonpolyposis Colorectal Cancer	1/128	0.05007601395994044	0.0586564545541999	0	0	22.34533183352081	66.90668639044372	CDH1
Rett Syndrome	1/129	0.050458430115721514	0.05889759372499894	0	0	22.169642857142858	66.21197613100185	VEGFA
tumor vasculature	1/129	0.050458430115721514	0.05889759372499894	0	0	22.169642857142858	66.21197613100185	VEGFA
Chronic liver disease	1/129	0.050458430115721514	0.05889759372499894	0	0	22.169642857142858	66.21197613100185	VEGFA
early pregnancy	1/129	0.050458430115721514	0.05889759372499894	0	0	22.169642857142858	66.21197613100185	VEGFA
Endometrial adenocarcinoma	1/129	0.050458430115721514	0.05889759372499894	0	0	22.169642857142858	66.21197613100185	VEGFA
Disorder of eye	1/131	0.05122285833690137	0.059748061332833204	0	0	21.826373626373627	64.85858386485305	VEGFA
Sleep Apnea, Obstructive	1/132	0.05160487048846722	0.0601095837812593	0	0	21.65866957470011	64.1993119748582	VEGFA
Mouth Neoplasms	1/132	0.05160487048846722	0.0601095837812593	0	0	21.65866957470011	64.1993119748582	VIM
Lewy Body Disease	1/133	0.05198674804787824	0.060469941243975533	0	0	21.493506493506494	63.55127863735061	VEGFA
beta Thalassemia	1/133	0.05198674804787824	0.060469941243975533	0	0	21.493506493506494	63.55127863735061	COL1A1
Skin Carcinogenesis	1/134	0.052368491061118044	0.06087152828567589	0	0	21.330827067669173	62.91421182271069	VEGFA
Middle Cerebral Artery Occlusion	1/135	0.05275009956416967	0.06118718085746524	0	0	21.17057569296375	62.287848035380144	VEGFA
Mycoses	1/135	0.05275009956416967	0.06118718085746524	0	0	21.17057569296375	62.287848035380144	MECOM
Neurilemmoma	1/135	0.05275009956416967	0.06118718085746524	0	0	21.17057569296375	62.287848035380144	VEGFA
Follicular adenoma	1/136	0.053131573605237785	0.06145871343518489	0	0	21.012698412698413	61.67193197685215	CD68
Melanoma, B16	1/136	0.053131573605237785	0.06145871343518489	0	0	21.012698412698413	61.67193197685215	VEGFA
Vasculitis	1/136	0.053131573605237785	0.06145871343518489	0	0	21.012698412698413	61.67193197685215	VEGFA
Cholelithiasis	1/136	0.053131573605237785	0.06145871343518489	0	0	21.012698412698413	61.67193197685215	VEGFA
Periodontal Diseases	1/137	0.05351291321651436	0.06181408534982407	0	0	20.857142857142858	61.06621624401382	VEGFA
Pruritus	1/137	0.05351291321651436	0.06181408534982407	0	0	20.857142857142858	61.06621624401382	VEGFA
Myocardial Infarction	2/966	0.053753123971073534	0.06203960632348411	0	0	6.5795297372060855	19.234291241343307	COL1A1;VEGFA
Hamartoma Syndrome, Multiple	1/138	0.05389411844288278	0.06203960632348411	0	0	20.70385818561001	60.47046101876616	VEGFA
Ureteral obstruction	1/138	0.05389411844288278	0.06203960632348411	0	0	20.70385818561001	60.47046101876616	VEGFA
Collecting Duct Carcinoma of the Kidney	1/138	0.05389411844288278	0.06203960632348411	0	0	20.70385818561001	60.47046101876616	VIM
Psoriasis vulgaris	1/138	0.05389411844288278	0.06203960632348411	0	0	20.70385818561001	60.47046101876616	VIM
Differentiated Thyroid Gland Carcinoma	1/139	0.05427518932356743	0.06243518330462792	0	0	20.5527950310559	59.884433789824605	VEGFA
Coronary Artery Disease	2/981	0.05526842634321525	0.06353393186801037	0	0	6.473612529792305	18.744691325784974	CD68;VEGFA
Vascular inflammations	1/142	0.055417596312302815	0.06361772240118452	0	0	20.112462006079028	58.18249888054842	VEGFA
Clear-cell metastatic renal cell carcinoma	1/142	0.055417596312302815	0.06361772240118452	0	0	20.112462006079028	58.18249888054842	VEGFA
Disease Exacerbation	1/144	0.05617852998582404	0.06444689684756155	0	0	19.829170829170828	57.0925576041236	CDH1
Frontotemporal dementia	1/145	0.05655879565354824	0.06470512424562308	0	0	19.69047619047619	56.56039175174553	VEGFA
Mammary Carcinoma, Animal	1/145	0.05655879565354824	0.06470512424562308	0	0	19.69047619047619	56.56039175174553	CDH1
Thrombocythemia, Essential	1/145	0.05655879565354824	0.06470512424562308	0	0	19.69047619047619	56.56039175174553	VEGFA
Animal Mammary Neoplasms	1/145	0.05655879565354824	0.06470512424562308	0	0	19.69047619047619	56.56039175174553	CDH1
Glaucoma, Primary Open Angle	1/147	0.05731892484401968	0.06548490865741427	0	0	19.418786692759294	55.520727497935795	COL1A1
Hematological Disease	1/147	0.05731892484401968	0.06548490865741427	0	0	19.418786692759294	55.520727497935795	VEGFA
Low-set, posteriorly rotated ears	1/149	0.0580785181093375	0.06630730198930523	0	0	19.154440154440156	54.51275945819848	COL1A1
Mild cognitive disorder	1/150	0.0584581138777585	0.06669503006026073	0	0	19.024928092042185	54.02023282333744	VEGFA
Malignant Squamous Cell Neoplasm	1/151	0.058837575784460396	0.06703625437737701	0	0	18.897142857142857	53.53512542876957	CD68
Primary Sj??gren's syndrome	1/151	0.058837575784460396	0.06703625437737701	0	0	18.897142857142857	53.53512542876957	CD68
Osteochondrodysplasias	1/152	0.05921690386794933	0.06733046738359882	0	0	18.77105014191107	53.05727873294568	VEGFA
Decreased platelet count	1/152	0.05921690386794933	0.06733046738359882	0	0	18.77105014191107	53.05727873294568	MECOM
Pre-Eclampsia	1/152	0.05921690386794933	0.06733046738359882	0	0	18.77105014191107	53.05727873294568	VEGFA
Sezary Syndrome	1/153	0.05959609817777477	0.06766936130737121	0	0	18.646616541353385	52.586538580428204	VIM
Primary Effusion Lymphoma	1/153	0.05959609817777477	0.06766936130737121	0	0	18.646616541353385	52.586538580428204	VEGFA
Abnormality of metabolism/homeostasis	1/155	0.06035408561800151	0.06834393401956994	0	0	18.4025974025974	51.66578236108292	CDH1
Aplastic Anemia	1/155	0.06035408561800151	0.06834393401956994	0	0	18.4025974025974	51.66578236108292	MECOM
Biliary cirrhosis	1/155	0.06035408561800151	0.06834393401956994	0	0	18.4025974025974	51.66578236108292	COL1A1
Platelet hematocrit measurement	1/155	0.06035408561800151	0.06834393401956994	0	0	18.4025974025974	51.66578236108292	MECOM
Mucocutaneous Lymph Node Syndrome	1/156	0.06073287883778701	0.06872621567261109	0	0	18.28294930875576	51.21547862254709	VEGFA
Curvature of little finger	1/157	0.06111153843461084	0.06910782787046162	0	0	18.164835164835164	50.771705823231116	MECOM
Intestinal Neoplasms	1/158	0.06149006445754368	0.06948877202925668	0	0	18.048225659690626	50.334329635540946	VEGFA
Clinodactyly of the 5th finger	1/159	0.061868456951280446	0.06986904955635462	0	0	17.933092224231466	49.90321931291774	MECOM
Mammary Neoplasms, Experimental	1/160	0.062246715938089725	0.07024866182999571	0	0	17.81940700808625	49.47824757789535	CDH1
Polycystic Kidney, Autosomal Dominant	1/161	0.06262484148102337	0.07062761027068762	0	0	17.707142857142856	49.05929049133134	VEGFA
Nephritis	1/162	0.06300283360189707	0.07100589624862454	0	0	17.596273291925467	48.646227367856696	VEGFA
Allergic rhinitis (disorder)	1/163	0.06338069234730123	0.0713353541398775	0	0	17.486772486772487	48.23894065290774	VIM
androgen independent prostate cancer	1/163	0.06338069234730123	0.0713353541398775	0	0	17.486772486772487	48.23894065290774	VIM
TARSAL-CARPAL COALITION SYNDROME	1/165	0.06413600988414846	0.07208818361641484	0	0	17.27177700348432	47.441241327220496	VEGFA
Bone Diseases	1/165	0.06413600988414846	0.07208818361641484	0	0	17.27177700348432	47.441241327220496	COL1A1
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	1/166	0.06451346874924052	0.07222044689512296	0	0	17.166233766233766	47.050608420266336	CDH1
Acute GVH disease	1/166	0.06451346874924052	0.07222044689512296	0	0	17.166233766233766	47.050608420266336	VEGFA
invasive cancer	1/166	0.06451346874924052	0.07222044689512296	0	0	17.166233766233766	47.050608420266336	VIM
Malignant neoplasm of brain	1/166	0.06451346874924052	0.07222044689512296	0	0	17.166233766233766	47.050608420266336	VEGFA
Classical Hodgkin's Lymphoma	1/166	0.06451346874924052	0.07222044689512296	0	0	17.166233766233766	47.050608420266336	VEGFA
Contracture	1/166	0.06451346874924052	0.07222044689512296	0	0	17.166233766233766	47.050608420266336	COL1A2
Progressive Neoplastic Disease	1/167	0.064890794410552	0.07259412815345455	0	0	17.061962134251292	46.66531114088834	VEGFA
Cleft upper lip	1/169	0.06564504623486145	0.07333954261202204	0	0	16.857142857142858	45.91031290242987	CDH1
Progressive cGVHD	1/169	0.06564504623486145	0.07333954261202204	0	0	16.857142857142858	45.91031290242987	VEGFA
Dental caries	1/170	0.06602197248496659	0.07371127851735225	0	0	16.756551141166526	45.54041305138296	CDH1
Fever	1/173	0.06715195309796386	0.07492271422568811	0	0	16.461794019933556	44.459968362117436	COL1A1
Drug Dependence	1/175	0.06790460877448139	0.07571182315229609	0	0	16.27093596059113	43.763145210735054	NFASC
Anaplastic thyroid carcinoma	1/176	0.06828073731864787	0.07592817989833643	0	0	16.177142857142858	43.421515351442125	VEGFA
Liver Failure	1/176	0.06828073731864787	0.07592817989833643	0	0	16.177142857142858	43.421515351442125	VEGFA
Mammary Tumorigenesis	1/176	0.06828073731864787	0.07592817989833643	0	0	16.177142857142858	43.421515351442125	VEGFA
Multiple malignancy	1/176	0.06828073731864787	0.07592817989833643	0	0	16.177142857142858	43.421515351442125	VEGFA
Hemoglobin low	1/177	0.0686567330509577	0.07624462764913278	0	0	16.084415584415584	43.084295807704265	MECOM
Platelet mean volume determination (procedure)	1/177	0.0686567330509577	0.07624462764913278	0	0	16.084415584415584	43.084295807704265	NFASC
Epilepsy, Temporal Lobe	1/181	0.07015938867849662	0.07775804672141685	0	0	15.723809523809523	41.77793617696802	VEGFA
Gastritis	1/181	0.07015938867849662	0.07775804672141685	0	0	15.723809523809523	41.77793617696802	CDH1
Conductive hearing loss	1/181	0.07015938867849662	0.07775804672141685	0	0	15.723809523809523	41.77793617696802	CDH1
Primary Myelofibrosis	1/182	0.07053472095805195	0.07812212122047188	0	0	15.636148382004736	41.461595899019535	VEGFA
Proteinuria	1/184	0.07128498785471031	0.07890070321277823	0	0	15.463700234192038	40.84070739750899	VEGFA
Adrenocortical carcinoma	1/185	0.07165992254120956	0.07921057044316603	0	0	15.378881987577639	40.53602082307047	VIM
MIXED LINEAGE LEUKEMIA	1/185	0.07165992254120956	0.07921057044316603	0	0	15.378881987577639	40.53602082307047	MECOM
Hashimoto Disease	1/186	0.07203472477672826	0.07951947116319175	0	0	15.294980694980694	40.235083092404665	VEGFA
Respiratory Distress Syndrome, Adult	1/186	0.07203472477672826	0.07951947116319175	0	0	15.294980694980694	40.235083092404665	VEGFA
Childhood Glioblastoma	1/187	0.07240939460960238	0.07988020516456136	0	0	15.211981566820276	39.93782890466653	VEGFA
Malignant Peripheral Nerve Sheath Tumor	1/188	0.07278393207000271	0.08018731749852345	0	0	15.12987012987013	39.64419443644198	VEGFA
Bronchopulmonary Dysplasia	1/188	0.07278393207000271	0.08018731749852345	0	0	15.12987012987013	39.64419443644198	VEGFA
Adult Glioblastoma	1/189	0.07315833720777766	0.08054660492579085	0	0	15.048632218844984	39.35411729295222	VEGFA
Platelet Count measurement	1/191	0.07390675063993561	0.08131692616583945	0	0	14.888721804511277	38.784392344873616	MECOM
Inflammatory disorder	1/192	0.07428075901853666	0.08167455902631453	0	0	14.81002243829469	38.50462656889652	VEGFA
Mean Corpuscular Volume (result)	1/194	0.07502837931017566	0.08238797675403094	0	0	14.655070318282753	37.955003157820386	CDH1
Eclampsia	1/194	0.07502837931017566	0.08238797675403094	0	0	14.655070318282753	37.955003157820386	VEGFA
Spinal Muscular Atrophy	1/196	0.07577547125294778	0.08315360924336639	0	0	14.503296703296703	37.41822466643311	VIM
Allergic asthma	1/197	0.07614881918277594	0.08350836975468132	0	0	14.428571428571429	37.154519475533114	VEGFA
Epilepsy	2/1177	0.07647799801189527	0.08380745544134649	0	0	5.338156028368794	13.723076285566966	COL1A1;VIM
Congenital clubfoot	1/198	0.07652203515417907	0.08380745544134649	0	0	14.354604786076868	36.89386843909958	COL1A1
Reticulocyte count (procedure)	1/202	0.07801358011308765	0.08538494201353689	0	0	14.066098081023455	35.88082085621993	CDH1
Papilloma	1/204	0.07875856181675209	0.08614379089202785	0	0	13.926108374384237	35.39137016593114	VEGFA
Cervical Intraepithelial Neoplasia	1/205	0.07913085511201665	0.08643763348188852	0	0	13.857142857142858	35.15075472727737	VEGFA
Embryonal Carcinoma	1/205	0.07913085511201665	0.08643763348188852	0	0	13.857142857142858	35.15075472727737	VIM
Childhood Osteosarcoma	1/206	0.07950301676620158	0.08678732458509439	0	0	13.788850174216028	34.91282137953759	VEGFA
Adenoid Cystic Carcinoma	1/208	0.08024694526730178	0.08754212210978375	0	0	13.654244306418219	34.444832741687804	CDH1
Trisomy	1/209	0.08061871219640526	0.08789020388470847	0	0	13.587912087912088	34.214695475566714	COL1A2
Germ cell tumor	1/210	0.08099034764934519	0.08812257004508009	0	0	13.522214627477785	33.98707630579846	VEGFA
Glomerulonephritis	1/210	0.08099034764934519	0.08812257004508009	0	0	13.522214627477785	33.98707630579846	VEGFA
Lupus Nephritis	1/210	0.08099034764934519	0.08812257004508009	0	0	13.522214627477785	33.98707630579846	VEGFA
Lymphoid leukemia	1/213	0.08210446543716779	0.08921840283335236	0	0	13.328840970350404	33.31894180822053	MECOM
Carcinoid Tumor	1/213	0.08210446543716779	0.08921840283335236	0	0	13.328840970350404	33.31894180822053	VEGFA
Craniosynostosis	1/214	0.08247557532114909	0.08956332007531034	0	0	13.26559356136821	33.10101327412349	VIM
Restenosis	1/215	0.08284655391141456	0.0899076460144694	0	0	13.202937249666222	32.88541571880503	VEGFA
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	1/216	0.08321740124957575	0.09007568156021567	0	0	13.140863787375416	32.67211391005441	VEGFA
Adenocarcinoma of prostate	1/216	0.08321740124957575	0.09007568156021567	0	0	13.140863787375416	32.67211391005441	VEGFA
Alopecia	1/216	0.08321740124957575	0.09007568156021567	0	0	13.140863787375416	32.67211391005441	COL1A1
Carcinoma	1/216	0.08321740124957575	0.09007568156021567	0	0	13.140863787375416	32.67211391005441	CDH1
Severe Combined Immunodeficiency	1/217	0.08358811737340943	0.09041827482415495	0	0	13.079365079365079	32.46107330597877	VEGFA
Neoplasm, Residual	1/220	0.0846994788808161	0.09156106984653353	0	0	12.898238747553815	31.841183296839475	MECOM
Status Epilepticus	1/221	0.08506967055696874	0.09190169073123307	0	0	12.838961038961038	31.638855311433936	VEGFA
Downward slant of palpebral fissure	1/222	0.08543973122300434	0.09224172924269984	0	0	12.780219780219781	31.43862560059154	COL1A1
Acute Erythroblastic Leukemia	1/224	0.08617945966503399	0.09298016734882063	0	0	12.664317745035234	31.044338644375678	VEGFA
Pulmonary Emphysema	1/225	0.08654912752993957	0.09331864558496393	0	0	12.607142857142858	30.85022166120884	VEGFA
Graft-vs-Host Disease	1/226	0.0869186645442068	0.09359608293075335	0	0	12.550476190476191	30.658083452983	VEGFA
Ventricular Septal Defects	1/226	0.0869186645442068	0.09359608293075335	0	0	12.550476190476191	30.658083452983	VEGFA
Anemia, Sickle Cell	1/231	0.08876438815202797	0.09552193512102107	0	0	12.274534161490683	29.726095450847716	VEGFA
Hypoglycemia	1/232	0.08913314087389414	0.09585691745819176	0	0	12.220779220779221	29.545249903179535	VEGFA
Encephalopathies	1/234	0.08987025462085924	0.09658736128066572	0	0	12.11465358675659	29.18890417560212	VEGFA
Hepatoblastoma	1/235	0.09023861572697534	0.09692080555865734	0	0	12.062271062271062	29.013354426090743	VEGFA
Periodontitis	1/237	0.0909749466079494	0.09764878438999974	0	0	11.958837772397095	28.66738056511164	VEGFA
Hepatitis B, Chronic	1/238	0.09134291644974413	0.09791772791656377	0	0	11.907775768535263	28.496909511669713	CDH1
Overweight	1/238	0.09134291644974413	0.09791772791656377	0	0	11.907775768535263	28.496909511669713	VEGFA
Medullary carcinoma of thyroid	1/239	0.0917107559627223	0.09824890234156762	0	0	11.857142857142858	28.328085107499632	VEGFA
Pituitary Diseases	1/240	0.09207846518591313	0.09857951215025872	0	0	11.806933652121936	28.160884911121965	VEGFA
Hypertensive disease	2/1310	0.09222632858003503	0.09867448112347557	0	0	4.761467889908257	11.349004567330011	COL1A1;VEGFA
Vitiligo	1/243	0.09318081142653449	0.09963179067914073	0	0	11.65879574970484	27.66881105269825	CDH1
Liver neoplasms	2/1321	0.09357325333409043	0.09998730721413379	0	0	4.71897902451352	11.179311761149556	VIM;VEGFA
Acute myocardial infarction	1/247	0.09464878461020683	0.10100714825964492	0	0	11.466898954703833	27.03415734979564	VEGFA
Diabetic Retinopathy	1/247	0.09464878461020683	0.10100714825964492	0	0	11.466898954703833	27.03415734979564	VEGFA
Brain Diseases	1/250	0.09574839954319952	0.10211530079159643	0	0	11.327022375215146	26.57354977580402	VEGFA
Patent ductus arteriosus	1/251	0.09611467805938048	0.10244043642367198	0	0	11.281142857142857	26.422842132081932	VEGFA
Alzheimer Disease, Late Onset	1/253	0.09684684568436021	0.10315487777874384	0	0	11.19047619047619	26.125559419255854	VEGFA
Congenital Epicanthus	1/255	0.09757849431533867	0.10386785482960109	0	0	11.101237345331834	25.833668944232098	COL1A1
Urothelial Carcinoma	1/257	0.0983096242767975	0.10451271720439659	0	0	11.013392857142858	25.547033361818187	VEGFA
Neuroendocrine Tumors	1/257	0.0983096242767975	0.10451271720439659	0	0	11.013392857142858	25.547033361818187	VEGFA
Behcet Syndrome	1/258	0.09867499486063239	0.10483432575002218	0	0	10.969983324068927	25.405644473217492	VEGFA
Sjogren's Syndrome	1/260	0.09940534740115749	0.1054759029676404	0	0	10.884169884169884	25.126643528793366	CD68
Lymphoma, T-Cell, Cutaneous	1/260	0.09940534740115749	0.1054759029676404	0	0	10.884169884169884	25.126643528793366	VEGFA
Hepatitis A	1/261	0.09977032944438723	0.10579587381642587	0	0	10.841758241758242	24.98899987392633	CD68
Renal Insufficiency	1/263	0.1004999052880969	0.10650180560390446	0	0	10.757906215921484	24.717349119115873	VEGFA
Brain Ischemia	1/264	0.1008644991478436	0.10682030766895435	0	0	10.71645844649647	24.58331193553308	VEGFA
Refractory anemias	1/266	0.10159329899237998	0.10752387228381333	0	0	10.634501347708895	24.318740541198824	VIM
Memory impairment	1/267	0.10195750503475176	0.10784091211031449	0	0	10.593984962406015	24.188177671180238	VEGFA
Pancreatitis	1/269	0.10268552958497451	0.10854211872480195	0	0	10.513859275053305	23.930427629401827	VEGFA
Cerebral Ischemia	1/275	0.10486650566547216	0.11077728400887116	0	0	10.280500521376434	23.183218623960414	VEGFA
Bacterial Infections	1/276	0.10522955036185379	0.1110904367111216	0	0	10.242597402597402	23.062346221118663	VEGFA
Congenital Heart Defects	1/277	0.10559246623050361	0.11126230806852812	0	0	10.20496894409938	22.942487200619283	VEGFA
Depressed nasal bridge	1/277	0.10559246623050361	0.11126230806852812	0	0	10.20496894409938	22.942487200619283	COL1A1
Dwarfism	1/277	0.10559246623050361	0.11126230806852812	0	0	10.20496894409938	22.942487200619283	COL1A2
Essential Hypertension	1/278	0.10595525328401989	0.11157409247332398	0	0	10.16761217122228	22.823629607457274	VEGFA
Pheochromocytoma	1/280	0.10668044112882412	0.1122668617052862	0	0	10.093701996927804	22.588871779629923	VEGFA
Anteverted nostril	1/283	0.10776725785783521	0.11326766610388729	0	0	9.984802431610943	22.243957110756586	COL1A1
Low density lipoprotein cholesterol measurement	1/283	0.10776725785783521	0.11326766610388729	0	0	9.984802431610943	22.243957110756586	MECOM
Anoxia	1/288	0.10957604822957528	0.11509625217061183	0	0	9.80836236933798	21.68762771053286	VEGFA
Migraine Disorders	1/290	0.11029866549947512	0.11578236252556608	0	0	9.739495798319327	21.47133647420108	VEGFA
Kidney Failure	1/297	0.11282378668513895	0.11835853848478728	0	0	9.505791505791505	20.740953478322734	VEGFA
Hereditary Diffuse Gastric Cancer	1/300	0.1139040603715798	0.11934169139434365	0	0	9.4089823220258	20.4400615348683	CDH1
Choriocarcinoma	1/300	0.1139040603715798	0.11934169139434365	0	0	9.4089823220258	20.4400615348683	VEGFA
Serum total cholesterol measurement	1/307	0.11642022412830887	0.12190140228877538	0	0	9.19047619047619	19.764569490964686	MECOM
Peripheral Neuropathy	1/309	0.11713797878839508	0.12257600289776852	0	0	9.12987012987013	19.578118459666744	VEGFA
Kidney Failure, Acute	1/310	0.11749666476286377	0.12287425506235533	0	0	9.099861303744799	19.485945513680498	VEGFA
Cholestasis	1/315	0.1192881826983526	0.12466960447421815	0	0	8.952684258416742	19.035313745752003	COL1A1
Kaposi Sarcoma	1/323	0.1221479926701053	0.12757849203114316	0	0	8.726708074534162	18.34809497017889	VEGFA
Hepatitis, Toxic	1/325	0.1228616742783758	0.12792339119621152	0	0	8.671957671957673	18.182460314131013	VIM
Heart Diseases	1/325	0.1228616742783758	0.12792339119621152	0	0	8.671957671957673	18.182460314131013	VEGFA
Chemical and Drug Induced Liver Injury	1/325	0.1228616742783758	0.12792339119621152	0	0	8.671957671957673	18.182460314131013	VIM
Chemically-Induced Liver Toxicity	1/325	0.1228616742783758	0.12792339119621152	0	0	8.671957671957673	18.182460314131013	VIM
Drug-Induced Acute Liver Injury	1/325	0.1228616742783758	0.12792339119621152	0	0	8.671957671957673	18.182460314131013	VIM
Impaired glucose tolerance	1/326	0.12321832466282187	0.12821470089681028	0	0	8.644835164835165	18.10053425428911	CD68
Hepatitis, Drug-Induced	1/329	0.12428751457712757	0.12908566271148741	0	0	8.564459930313589	17.858249838876702	VIM
Diarrhea	1/329	0.12428751457712757	0.12908566271148741	0	0	8.564459930313589	17.858249838876702	VEGFA
Primary biliary cirrhosis	1/329	0.12428751457712757	0.12908566271148741	0	0	8.564459930313589	17.858249838876702	COL1A1
Graves Disease	1/335	0.12642247244109528	0.1312213341827921	0	0	8.408041060735671	17.388888535059372	VEGFA
Triglycerides measurement	1/336	0.12677785561470892	0.13142663963041296	0	0	8.382515991471216	17.31256864380974	COL1A2
Mood Disorders	1/336	0.12677785561470892	0.13142663963041296	0	0	8.382515991471216	17.31256864380974	VEGFA
Lens Opacities	1/339	0.1278432462383505	0.1323665640754616	0	0	8.306846999154692	17.08677229343787	VIM
Pneumonitis	1/339	0.1278432462383505	0.1323665640754616	0	0	8.306846999154692	17.08677229343787	VEGFA
Thrombocytopenia	1/341	0.12855287461902729	0.13301873130554437	0	0	8.257142857142858	16.938826579242562	MECOM
Recurrent tumor	1/347	0.13067872939283798	0.13513460671249458	0	0	8.111478117258464	16.50696678684803	VEGFA
Encephalomyelitis	1/348	0.13103259701141043	0.13541658724599293	0	0	8.087690407575133	16.436687254775542	VEGFA
Ewings sarcoma	1/352	0.13244680737013861	0.1367933589432763	0	0	7.993894993894994	16.16025162112513	VEGFA
Adenocarcinoma of pancreas	1/354	0.1331531570366007	0.1374377883273824	0	0	7.947794415216512	16.024782268271085	VEGFA
Presenile dementia	1/362	0.13597352620355355	0.14026211608381406	0	0	7.768500197863078	15.50045016522282	VEGFA
Leukemia, T-Cell	1/364	0.13667736263781988	0.14090101414084275	0	0	7.7249114521841795	15.373594619983068	VEGFA
Central neuroblastoma	2/1655	0.13726031325433727	0.14141457844856983	0	0	3.6981246218995767	7.344017150965674	VIM;VEGFA
Precursor B-cell lymphoblastic leukemia	1/367	0.1377321766485057	0.14181313003068366	0	0	7.660421545667448	15.186358480642427	VEGFA
Abnormal behavior	1/372	0.13948769418479828	0.14353206286258083	0	0	7.555256064690027	14.88218394512216	COL1A1
Diabetes Mellitus, Non-Insulin-Dependent	2/1672	0.13961193455940107	0.1435713359094211	0	0	3.6570858283433134	7.200394601016316	CD68;VEGFA
Hyperinsulinism	1/377	0.14124008358079218	0.14506678535268555	0	0	7.452887537993921	14.587492926501362	VEGFA
Drug-Induced Liver Disease	1/377	0.14124008358079218	0.14506678535268555	0	0	7.452887537993921	14.587492926501362	VIM
Chronic Kidney Diseases	1/380	0.1422900177078547	0.1460552304841241	0	0	7.392762909913306	14.415059137639451	VEGFA
Glaucoma	1/381	0.14263974603941806	0.1463241675238311	0	0	7.372932330827068	14.35829236085336	VEGFA
Age related macular degeneration	1/382	0.14298934961380272	0.14659264606995878	0	0	7.353205849268841	14.301876032605566	VEGFA
Neuroblastoma	2/1698	0.14322945417187055	0.14674860538002463	0	0	3.5959119496855347	6.987962157909211	VIM;VEGFA
Gastric Adenocarcinoma	1/383	0.1433388284514488	0.14677051311050743	0	0	7.3335826477187736	14.245807129706114	VEGFA
Erythrocyte Mean Corpuscular Hemoglobin Test	1/387	0.14473549707744301	0.1480188897150061	0	0	7.2561065877128055	14.024946465209085	CDH1
Finding of Mean Corpuscular Hemoglobin	1/387	0.14473549707744301	0.1480188897150061	0	0	7.2561065877128055	14.024946465209085	CDH1
Ischemic stroke	1/394	0.1471748733802357	0.1504213779400938	0	0	7.124318429661941	13.651147233919568	VEGFA
Ataxia Telangiectasia	1/396	0.14787071888426198	0.15104002394301835	0	0	7.0875226039783	13.547210541162373	VIM
Vascular Diseases	1/401	0.14960815965295157	0.15272118133483673	0	0	6.997142857142857	13.292721886356231	VEGFA
Dermatologic disorders	1/406	0.15134249990642432	0.15439711917059068	0	0	6.908994708994709	13.045631513349893	VEGFA
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	1/408	0.15203536892875155	0.1550091658760132	0	0	6.874341874341875	12.948799729129462	MECOM
Retinitis Pigmentosa	1/410	0.15272774293736988	0.15561996042732615	0	0	6.8400279427174295	12.853085567434091	VEGFA
Cardiomyopathy, Dilated	1/419	0.15583730826401543	0.158691471419034	0	0	6.6896787423103214	12.435729541433163	VEGFA
Fatty Liver	1/443	0.16408071519980422	0.16698391272316865	0	0	6.318681318681318	11.420364435913557	VEGFA
Myocardial Ischemia	1/448	0.1657891978807249	0.16861974516161535	0	0	6.2464046021093	11.225027619600391	VEGFA
Septicemia	1/468	0.17259261404620668	0.17543234627000168	0	0	5.972774548791679	10.493097508978673	VEGFA
Down Syndrome	1/475	0.1749623128808663	0.17773272709213458	0	0	5.882459312839059	10.254212973790082	VEGFA
Cardiomyopathies	1/480	0.17665131704133677	0.17933925552340216	0	0	5.819564569042648	10.088665903095116	VEGFA
Glioblastoma	2/1937	0.17754715652462463	0.18013908581695492	0	0	3.110594315245478	5.376721483410054	VIM;VEGFA
Hyperglycemia	1/488	0.1793474310330127	0.18185502429365663	0	0	5.721619243179818	9.832204438239485	VEGFA
Genetic Diseases, Inborn	1/507	0.18571976346516506	0.188202044629341	0	0	5.501411631846414	9.261716647275623	COL1A2
Major Depressive Disorder	1/513	0.18772306325940077	0.19011661780004885	0	0	5.435267857142857	9.092047967263175	VEGFA
Unipolar Depression	1/517	0.18905619939244717	0.19135057074429726	0	0	5.392026578073089	8.981557750667953	VEGFA
Cataract	1/519	0.18972204925696226	0.19190805225022015	0	0	5.370656370656371	8.927079114213411	VIM
Sepsis	1/529	0.1930441280128553	0.19515006395481374	0	0	5.266233766233766	8.662093377512331	VEGFA
Retinoblastoma	1/539	0.1963542829185629	0.19825601931486864	0	0	5.165693043016463	8.40889431018134	VEGFA
Lymphoma, Non-Hodgkin	1/539	0.1963542829185629	0.19825601931486864	0	0	5.165693043016463	8.40889431018134	VEGFA
Metabolic Syndrome X	1/548	0.19932325778576296	0.201131998782004	0	0	5.078349438495691	8.190500924152634	VEGFA
Mental Depression	1/575	0.2081726774892091	0.20993471949939588	0	0	4.832752613240418	7.584460881915175	VEGFA
Tuberculosis	1/602	0.2169363970543415	0.21864042917621848	0	0	4.609222724031376	7.0435886354594555	VIM
Congenital Abnormality	1/607	0.21854996043910568	0.22013365580460645	0	0	4.57001414427157	6.949806228573346	VEGFA
Huntington Disease	1/627	0.22497515878791563	0.2264686571262784	0	0	4.419443176631675	6.592771924336119	VEGFA
Kidney Diseases	1/639	0.2288080484696033	0.23018807288739343	0	0	4.333631885356024	6.391551646581382	VEGFA
Amyotrophic Lateral Sclerosis	1/660	0.23547570741081938	0.2367531524781475	0	0	4.190982007370475	6.060778253469809	VEGFA
Impaired cognition	1/671	0.23894811698075039	0.24009967417101905	0	0	4.119829424307036	5.897572217031175	VEGFA
Autistic Disorder	1/677	0.24083633571099736	0.24185129919683537	0	0	4.081994928148775	5.811281793858666	VEGFA
Depressive disorder	1/741	0.26072372104683733	0.2616649619170425	0	0	3.7166023166023168	4.996206091864273	VEGFA
Cardiovascular Diseases	1/787	0.2747347537777839	0.2755607752864363	0	0	3.490730643402399	4.509846587083221	VEGFA
HIV Infections	1/806	0.2804537620982358	0.2811279297955874	0	0	3.404968944099379	4.328895038514997	CD68
Bipolar Disorder	1/837	0.2897000853364985	0.29022206747223994	0	0	3.273410799726589	4.055458361167542	VEGFA
Parkinson Disease	1/1064	0.35429793440619983	0.3547232620585482	0	0	2.543878510952829	2.63957183615849	VEGFA
Lupus Erythematosus, Systemic	1/1113	0.3675467827597749	0.3677672667326362	0	0	2.4254881808838644	2.4276824434068605	VEGFA
Intellectual Disability	1/2503	0.6569300059561353	0.6569300059561353	0	0	0.9986296676944159	0.419602018792101	COL1A2
